Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,45303,0.0208039009993724,0.0120546536030866,-0.0028232200626774,0.0444310220614222,0.0843985169806685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,42133,0.0259318169579636,0.0137109071432686,-0.000941561042842848,0.0528051949587701,0.0585969585400638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1070.Time spent watching television (TV),46660,-0.00186839780785448,0.0122339975831849,-0.0258470330708969,0.0221102374551879,0.878619076936314
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1080.Time spent using computer,42168,-0.035136738087761,0.0129491154974372,-0.0605170044627379,-0.009756471712784,0.00666515986557903
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1090.Time spent driving,39899,0.0270074756207768,0.0142557135498345,-0.0009337229368989,0.0549486741784525,0.0581770903292669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1160.Sleep duration,47949,-4.84571135468415e-05,0.0111182408662848,-0.0218402092114651,0.0217432949843714,0.996522592967627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32513,0.070249474708908,0.0411643519603882,-0.010432655133453,0.150931604551269,0.087942208431648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32513,0.0913781472223458,0.0367726296063003,0.0193037931939972,0.163452501250694,0.0129770934520205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32513,-0.0449105585599439,0.0433559464192678,-0.129888213541709,0.040067096421821,0.300299955260596
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32513,-0.00122339819137114,0.0440597012764342,-0.0875804126931821,0.0851336163104399,0.977848809725232
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32513,-0.0484943040075347,0.0447074568295367,-0.136120919393427,0.0391323113783571,0.278085742636086
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32513,-0.0636349119844382,0.0862748360430253,-0.232733590628768,0.105463766659891,0.460788938225975
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32513,0.0318286638356941,0.0840643811913545,-0.132937523299361,0.196594850970749,0.704978203109711
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32513,-0.0173299278714572,0.0665217584604652,-0.147712574453969,0.113052718711055,0.794473061824604
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32513,-0.0189476100148246,0.0479141120374576,-0.112859269608241,0.0749640495785924,0.692521673542773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32513,0.0360211034514503,0.0330028828742405,-0.0286645469820611,0.100706753884962,0.275106117446819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32513,0.0810020952241924,0.0458176239314289,-0.00880044768140827,0.170804638129793,0.0771113644168985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32513,-0.00297418057285421,0.0280472195444351,-0.0579467308799471,0.0519983697342386,0.915551743336705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32513,0.0548492158953024,0.034906304940263,-0.013567141787613,0.123265573578218,0.116145983605997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32513,0.077177060124222,0.0498256022968719,-0.020481120377647,0.174835240626091,0.121434475746702
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32513,0.0394717447780029,0.0470035286394264,-0.0526551713552729,0.131598660911279,0.401067135073033
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32513,-0.016174590026701,0.0656365493239609,-0.144822226701664,0.112473046648262,0.805358311370213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32513,-0.0167468625262809,0.0619031568440227,-0.138077049940565,0.104583324888003,0.786756962537531
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32513,0.00472089998103297,0.0373077313479943,-0.0684022534610358,0.0778440534231018,0.899308075663206
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32513,-0.00670211302883403,0.0346333082122668,-0.074583397124877,0.0611791710672089,0.846559441340622
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32513,-0.0184657966888432,0.0461501533698933,-0.108920097293834,0.0719885039161476,0.689075587527077
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120040.Fatigue severity over the past week,32519,-0.0107841623697601,0.0189990397658231,-0.0480222803107733,0.0264539555712532,0.570311418191449
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32517,-0.012418992073453,0.0189155273075551,-0.049493425596261,0.024655441449355,0.511488955434089
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32516,0.00775555197337571,0.0202623163727482,-0.0319585881172108,0.0474696920639622,0.701909724756358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120098.Mobility problems today,32522,-0.0319182393248832,0.022426016922087,-0.0758732324921737,0.0120367538424072,0.154697060043088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120099.Self-care problems today,32522,-0.0443648862880604,0.035375197644338,-0.113700273670963,0.0249705010948421,0.209833257267381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120100.Problems doing usual activities,32522,0.00197859691649354,0.0212465607643483,-0.039664662181629,0.0436218560146161,0.92580615992946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120101.Pain or discomfort today,32522,0.0165582493970593,0.0190634605067697,-0.0208061331962093,0.0539226319903279,0.385099612273778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120102.Anxiety or depression today,32522,-0.00328874126821467,0.0223829782117881,-0.0471593785633194,0.0405818960268901,0.883190581468452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120103.Scale to indicate how health is today,32485,0.0147112883769139,0.0120769297305499,-0.00895949389496392,0.0383820706487916,0.223209786119814
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32499,-0.0223311110304885,0.0231337122969544,-0.067673187132519,0.023010965071542,0.334420588424024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32476,-0.00319803618772086,0.023282638463847,-0.048832007576861,0.0424359352014193,0.89075196941374
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32506,-0.000436551793214796,0.0187696012618935,-0.037224970266526,0.0363518666800964,0.981444692830114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32506,-0.00355529776200576,0.0192955548575205,-0.041374585282746,0.0342639897587345,0.853818245226524
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32510,-0.021297059747215,0.0234878261674146,-0.0673331990353477,0.0247390795409176,0.364577995154398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32482,-0.000534499250613434,0.0243152548878256,-0.0481923988307515,0.0471234003295247,0.982462817070617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32505,-0.0400797843272858,0.0252592697377022,-0.0895879530131822,0.00942838435861063,0.112611794635958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32496,-0.0598626129785104,0.0370606714290356,-0.13250152897942,0.0127763030223993,0.106293671721381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32463,0.0209833107756638,0.0501574841575062,-0.0773253581730483,0.119291979724376,0.6757035144917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30514,-0.00834491802661481,0.0251796384493648,-0.0576970093873698,0.0410071733341402,0.740342251534731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45911,0.00463909452467948,0.0270791451230547,-0.0484360299165077,0.0577142189658667,0.863976808252108
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44313,-0.0015486215053532,0.0175064527138814,-0.0358612688245608,0.0327640258138544,0.929511935268512
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1289.Cooked vegetable intake,47482,-0.0172990650304559,0.0116177643990886,-0.0400698832526696,0.00547175319175775,0.136496215638269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47054,-0.0406042848006952,0.0125543419711231,-0.0652107950640965,-0.0159977745372939,0.00122124052239377
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1309.Fresh fruit intake,47530,-0.00749710317889837,0.0120167154742142,-0.0310498655083582,0.0160556591505615,0.532706292093012
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1319.Dried fruit intake,46065,0.00276887498352591,0.0121125771609336,-0.020971776251904,0.0265095262189558,0.819185847791713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X134.Number of self-reported cancers,48202,-0.0274012200431887,0.0199692338268627,-0.0665409183438396,0.0117384782574622,0.170022914985107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48202,0.023418502644524,0.011494230960112,0.000889809962704591,0.0459471953263435,0.0416196726148675
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X136.Number of operations, self-reported",48202,-0.00694739766406826,0.0116102746850902,-0.029703536046845,0.0158087407187085,0.54958972987212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X137.Number of treatments or medications taken,48202,0.0148021507136337,0.0112838847786234,-0.00731426345246814,0.0369185648797356,0.189601780831742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1438.Bread intake,47384,0.00127192503207222,0.00777385949654351,-0.0139648395811531,0.0165086896452975,0.870035169972538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1458.Cereal intake,47008,0.00536232638894085,0.0115040714281855,-0.0171856536103027,0.0279103063881844,0.641131084923477
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1488.Tea intake,47401,-0.0167096337872455,0.00722788280123222,-0.0308762840776607,-0.00254298349683039,0.0207958820198507
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1498.Coffee intake,46343,0.0293616022313784,0.0116159259773745,0.00659438731572428,0.0521288171470324,0.0114881433514685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1528.Water intake,46725,-0.00712706212130392,0.0118630043269511,-0.030378550602128,0.0161244263595202,0.547992282013028
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1568.Average weekly red wine intake,38935,0.000384086018625078,0.0139771869408803,-0.0270112003855003,0.0277793724227505,0.978077674068486
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,38928,0.0094179041863166,0.0140366400569339,-0.0180939103252739,0.0369297186979071,0.502262155831443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,38955,-0.0196640979186876,0.0177857673101338,-0.0545242018465498,0.0151960060091746,0.268914291887884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1598.Average weekly spirits intake,38890,0.00969028544515439,0.0158215737189844,-0.0213199990440551,0.0407005699343639,0.540234556236689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,38957,0.073750803882393,0.024123763887791,0.0264682266623226,0.121033381102463,0.00223833105579261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,42513,-0.0377937001838434,0.0138794023325664,-0.0649973287556736,-0.0105900716120132,0.00647529445295526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1807.Father's age at death,41886,0.000813501371713384,0.00834006686895796,-0.0155330296914442,0.017160032434871,0.922297620430055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1845.Mother's age,33654,0.0103378539740103,0.0193029435120697,-0.0274959153096464,0.048171623257667,0.59227671339917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1873.Number of full brothers,47753,0.00397788342944511,0.0111729270228681,-0.0179210535353763,0.0258768203942666,0.721822245426657
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1883.Number of full sisters,47757,0.0231616151475068,0.011201103257688,0.00120745276243833,0.0451157775325753,0.0386700633369926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20015.Sitting height,48036,-0.0147208189004102,0.0095766208156423,-0.0334909956990691,0.00404935789824869,0.124267025469076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20016.Fluid intelligence score,32173,0.00200480603752729,0.0184967916277776,-0.0342489055529168,0.0382585176279714,0.913691778829683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20018.Prospective memory result,32463,0.0181288185189453,0.0245887179639523,-0.0300650686904013,0.0663227057282919,0.460972487401108
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32059,-0.0119735049687797,0.0131045887033578,-0.037658498827361,0.0137114888898016,0.360909788111718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32044,-0.00728207729701468,0.0130575775415172,-0.0328749292783884,0.018310774684359,0.577072693625297
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20023.Mean time to correctly identify matches,47926,0.00493228725103485,0.00787049675838126,-0.0104938863953924,0.0203584608974621,0.530874748975514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45440,-0.00346789684824945,0.0160787503886483,-0.0349822476100001,0.0280464539135012,0.82923773815686
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45075,-0.0545571632986174,0.0348453303598682,-0.122854010803959,0.0137396842067243,0.117435355055843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45047,0.00737106178201971,0.0476741781942302,-0.0860703274786715,0.100812451042711,0.877127703130661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45064,0.0207711151100878,0.0379741922302642,-0.05365830166123,0.0952005318814056,0.584398548838863
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45069,0.0102416113547658,0.0285565464135939,-0.0457292196158783,0.0662124423254098,0.719865692768892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,45203,-0.0296095191911903,0.0208577294725708,-0.0704906689574291,0.0112716305750484,0.155740773160063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45152,-0.0249641093447619,0.0262708843602826,-0.0764550426909158,0.026526824001392,0.341992436484219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45072,-0.0946348157732917,0.0335616296535459,-0.160415609894242,-0.0288540216523417,0.00481095481438977
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45212,0.0225960390916371,0.0236008038229089,-0.0236615364012644,0.0688536145845385,0.3383630900668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45251,-0.00401558571282173,0.0179349551813604,-0.0391680978682881,0.0311369264426447,0.82283951677051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45140,0.0179736736551175,0.0249431479506059,-0.0309148963280701,0.0668622436383051,0.471172647497985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46589,-0.00529289281531117,0.0178236823766791,-0.0402273102736022,0.0296415246429799,0.766501029071096
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46477,0.043162333336185,0.0260929840364698,-0.00797991537529581,0.0943045820476658,0.0981064326979421
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46420,-0.0178130534993037,0.0565728142961819,-0.12869576951982,0.0930696625212128,0.752863733913056
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46452,0.0385334154489777,0.0281188365249624,-0.0165795041399485,0.093646335037904,0.170583134940443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46537,0.0113228705410643,0.0205117952161584,-0.0288802480826061,0.0515259891647347,0.580941928369284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46432,-0.0691234538340786,0.0379740614461133,-0.143552614268461,0.00530570660030354,0.0687298512014096
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46432,0.0523878682588373,0.0336603377592053,-0.013586393749205,0.11836213026688,0.119635037794573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46457,-0.0142391182216982,0.0267031663829676,-0.0665773243323147,0.0380990878889183,0.593874868335765
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46476,0.0426484557995529,0.0300181807119072,-0.0161871783957852,0.101484089994891,0.155402391851372
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46622,-0.00351933338427259,0.0155129700801764,-0.0339247547414183,0.0268860879728732,0.820531640867021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46492,0.0208454464261219,0.0243743497505125,-0.0269282790848827,0.0686191719371265,0.392438321216627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43519,-0.0487642025490627,0.0253389336176119,-0.0984285124395821,0.000900107341456645,0.0543096468818611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43393,-0.0184224880342103,0.0996421877010587,-0.213721175928285,0.176876199859865,0.853320096857488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43391,0.0273321120923802,0.103052465109156,-0.174650719521565,0.229314943706325,0.790838858989161
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43447,0.0137696098326307,0.0282845155975829,-0.0416680407386319,0.0692072604038932,0.626387956119392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43404,0.0167067526588112,0.0595686114397545,-0.100047725763108,0.13346123108073,0.779125869564435
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43418,-0.0444052144167807,0.0426710208090954,-0.128040415202608,0.0392299863690464,0.298055453433317
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43399,0.0836660733156966,0.0522009224295645,-0.0186477346462498,0.185979881277643,0.109002108012361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43397,0.0484680786591363,0.0513945505848118,-0.0522652404870947,0.149201397805367,0.345662898729397
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43414,-0.0327925102450411,0.0369885767105767,-0.105290120597771,0.0397051001076893,0.37532827963135
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43420,0.000732517682303966,0.0451798172256706,-0.0878199240800103,0.0892849594446183,0.987064329270695
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43580,0.000646508008927013,0.0186962343870442,-0.0359981113896797,0.0372911274075337,0.972415342125077
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43476,0.0279221846592644,0.0268017791357917,-0.0246093024468873,0.0804536717654161,0.297516076018712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20127.Neuroticism score,43102,0.0178088415111833,0.01172903821639,-0.0051800733929412,0.0407977564153078,0.128941939548516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32173,0.0192801489260049,0.0188039271357022,-0.0175755482599714,0.0561358461119811,0.305241721383252
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20161.Pack years of smoking,30837,0.00401330386082242,0.0153905030384835,-0.0261520820946052,0.0341786898162501,0.794282178124426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30837,0.00533635496276029,0.015165705771255,-0.0243884283488994,0.03506113827442,0.724947464023592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20191.Fluid intelligence score,30358,0.0381362533037433,0.0211674526056254,-0.00335195380328258,0.0796244604107691,0.0716522242700299
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30358,0.0403677110885887,0.021745666750001,-0.00225379574141322,0.0829892179185906,0.0634526198995336
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20240.Maximum digits remembered correctly,29706,0.0472319455692621,0.0227639249865553,0.00261465259561372,0.0918492385429104,0.0380481958736725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20255.Spirometry QC measure,42652,0.053109577977273,0.01549654614388,0.0227363475352682,0.0834828084192778,0.000611214976043463
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20261.avMSE,29682,-0.0362884566781641,0.0149012230686495,-0.065494853892717,-0.00708205946361108,0.0149139997193668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20262.Myopia diagnosis,29682,0.0274304972855191,0.0279827650435196,-0.0274157221997792,0.0822767167708175,0.327001169032451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20280.Glucose-lactate,37677,0.10537566296775,0.010143360605412,0.0854946761811424,0.125256649754357,3.49117583241679e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37708,0.0971966651564842,0.00970031827612694,0.0781840413352754,0.116209288977693,1.51075494507274e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31899,0.0243454379711418,0.0456740780147595,-0.0651757549377869,0.11386663088007,0.594031990108892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31897,0.00442455763835209,0.0856958117841332,-0.163539233458549,0.172388348735253,0.958824129212707
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31895,-0.0702158119298422,0.109161279122144,-0.284171919009244,0.14374029514956,0.520094671716941
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31895,0.03730838866992,0.0429126916067345,-0.0468004868792797,0.12141726421912,0.38465521266244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31895,0.124249150041793,0.0845593383555842,-0.0414871531351521,0.289985453218738,0.141774098984411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31901,-0.0520976993432918,0.102400621429121,-0.25280291734437,0.148607518657786,0.610933069144315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31901,-0.0289847204341194,0.0690181600111116,-0.164260314055898,0.106290873187659,0.674528333026632
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31901,-0.0898852505916914,0.0759030867446206,-0.238655300611148,0.0588847994277651,0.236367436007316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31901,-0.0151185934799205,0.122384821979953,-0.254992844560628,0.224755657600787,0.901688187737398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31901,0.0361366744033916,0.147336477748939,-0.252642821984528,0.324916170791311,0.806256991427872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31901,-0.164534842204399,0.0798841233369568,-0.321107723944835,-0.00796196046396408,0.0394648762880056
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31901,0.074008466939578,0.150107452866592,-0.220202140678943,0.368219074558099,0.622001266004842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31901,0.0609817945474685,0.103713032424415,-0.142295749004385,0.264259338099322,0.556559621623547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31901,0.015078090089265,0.127135512275373,-0.234107513970467,0.264263694148997,0.905596595384408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31901,0.0081536634964323,0.0578562195147359,-0.10524452675245,0.121551853745315,0.887929237403993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31901,0.0335879358652638,0.0947457996798075,-0.152113831507159,0.219289703237686,0.722969890417232
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31902,0.216201939260933,0.146196616047485,-0.070343428192137,0.502747306714004,0.13922438125594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,33284,0.00660287003168706,0.0170551315129939,-0.026825187733781,0.0400309277971552,0.698655548770887
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20601.Liking for aniseed,33284,0.0107970824060736,0.0169705697539712,-0.0224652343117099,0.0440593991238571,0.524646988360978
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20602.Liking for apple juice,33284,0.0394624221481157,0.0170507118833937,0.00604302685666401,0.0728818174395675,0.0206678205801107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20603.Liking for apples,33284,0.0135204989611291,0.0174036078881689,-0.0205905724996819,0.0476315704219401,0.437250939400185
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20604.Liking for asparagus,33284,-0.0029755576847533,0.0174609384012747,-0.0371989969512517,0.0312478815817451,0.864689851506782
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20605.Liking for aubergine,33284,0.000560745080642976,0.0171115796271927,-0.0329779509886547,0.0340994411499406,0.973858807629071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20606.Liking for avocados,33284,0.0220192296772328,0.0175057455232873,-0.0122920315484103,0.0563304909028758,0.208486991211932
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20607.Liking for bacon,33284,0.015450631180052,0.0171301234089634,-0.0181244107015163,0.0490256730616203,0.367104441150501
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,33284,-0.00658580730440475,0.017482805674115,-0.0408521064256702,0.0276804918168607,0.70640415892975
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20609.Liking for bananas,33284,0.01379564771428,0.0178818338237158,-0.0212527465802029,0.0488440420087629,0.440437482304465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33284,-0.0130617287915179,0.0171770004833443,-0.0467286497388727,0.0206051921558368,0.447024097613798
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20611.Liking for beef steak,33284,-0.00307225531224338,0.0171544478340825,-0.036694973067045,0.0305504624425583,0.857868159609497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20612.Liking for beetroot,33284,0.0122908910564043,0.0175794951375355,-0.0221649194131653,0.0467467015259739,0.48447007597741
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20613.Liking for bell pepper,33284,-0.00979313307139914,0.0172336867527545,-0.0435711591067979,0.0239848929639996,0.569876117999537
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20614.Liking for bicycling,33284,0.016522713399402,0.0171020596475501,-0.0169973235097962,0.0500427503086003,0.33400852529433
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20615.Liking for biscuits,33284,0.0278423262077823,0.0171830265402175,-0.005836405811044,0.0615210582266085,0.10519523498504
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20616.Liking for bitter foods,33284,-0.0231795300334644,0.0170575397704839,-0.0566123079836128,0.010253247916684,0.174212285908349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20617.Liking for bitter or ale,33284,0.0159138363457873,0.0178080887650888,-0.0189900176337868,0.0508176903253614,0.371544444614505
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20618.Liking for black olives,33284,-0.00457879274708631,0.0172300738167687,-0.038349737427953,0.0291921519337804,0.79044240397174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20619.Liking for black pepper,33284,0.0325009289691005,0.0173048992195098,-0.00141667350113873,0.0664185314393397,0.0603957143817094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20620.Liking for blue cheese,33284,0.0341475565599319,0.0171269908967391,0.000578654402323325,0.0677164587175405,0.0462061649494382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,33284,0.00030811021415189,0.0172272169228926,-0.0334572349547176,0.0340734553830213,0.985730933114303
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20622.Liking for broad beans,33284,0.0151263031817988,0.0171595935379184,-0.0185065001525214,0.0487591065161189,0.378067436892089
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20623.Liking for broccoli,33284,-0.0019174090985002,0.0179228536994161,-0.0370462023493558,0.0332113841523554,0.914806295618552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20624.Liking for brown rice,33284,0.00317995933167055,0.0172148954774998,-0.030561235804229,0.0369211544675701,0.853451817761919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,33284,0.0287509864678274,0.0173670182064685,-0.00528836921685084,0.0627903421525056,0.0978599893748902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20626.Liking for burgers (meat),33284,-0.0275300163332287,0.0171032323812724,-0.0610523518005225,0.00599231913406512,0.107512636742069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,33284,-0.00985884240026842,0.0171989880691045,-0.0435688590157132,0.0238511742151763,0.566508839279215
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20628.Liking for butter on bread,33284,0.0449404598129908,0.0174487876429321,0.0107408360328439,0.0791400835931377,0.0100238177321947
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20629.Liking for butternut squash,33284,-0.00981728317813108,0.0171383655465917,-0.0434084796494508,0.0237739132931886,0.5667778292862
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20630.Liking for cabbage,33284,0.00373228929209586,0.0173907424111673,-0.030353565833792,0.0378181444179837,0.830073573954357
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20631.Liking for cake,33284,0.0148172527832609,0.0172429424439014,-0.0189789144067858,0.0486134199733076,0.390185820397269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20632.Liking for cake icing,33284,0.000500578051457342,0.0170119543107001,-0.0328428523975149,0.0338440085004295,0.976526239089467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20633.Liking for capers,33284,-0.0148714704496778,0.0170219384900178,-0.0482344698901127,0.0184915289907571,0.382324540860037
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20634.Liking for cauliflower,33284,-0.000524837892839591,0.0175423313454108,-0.0349078073298448,0.0338581315441656,0.976132835002235
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,33284,0.00985697343347411,0.0170453299323454,-0.0235518732339229,0.0432658201008711,0.563089852717872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20636.Liking for cheesecake,33284,0.0516938472482995,0.0171903569407892,0.0180007476443527,0.0853869468522463,0.00264459350580425
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20637.Liking for cherries,33284,0.0202527407654422,0.0186248206486196,-0.0162519077058523,0.0567573892367367,0.27688714781007
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20638.Liking for chicken,33284,-0.0142899681774015,0.0181812538769805,-0.0499252257762833,0.0213452894214804,0.431904621133825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20639.Liking for chilli pepper,33284,-0.0243224530120063,0.0171288957924346,-0.0578950887651781,0.00925018274116558,0.15565285457392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20640.Liking for chips or french fries,33284,0.00331614310902947,0.0171519158293687,-0.0303016119165332,0.0369338981345921,0.846697531026868
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,33284,-0.0549125825483429,0.0285115464439731,-0.11079521357853,0.000970048481844406,0.0541393394648452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20642.Liking for cod,33284,0.00765810821840449,0.0176705932177176,-0.026976254488322,0.0422924709251309,0.664748232079194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,33284,-0.000234929009136542,0.0195722706318912,-0.0385965794476434,0.0381267214293703,0.9904233688457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,33284,0.0192670961269695,0.0175329401348606,-0.0150974665373573,0.0536316587912963,0.271837984159831
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20645.Liking for coriander,33284,-0.00470588871001101,0.017177407972072,-0.0383736083352722,0.0289618309152502,0.784123294696263
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20646.Liking for corn flakes,33284,0.00925501269348553,0.0171303972496572,-0.0243205659158425,0.0428305913028136,0.589025568901895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20647.Liking for cream,33284,0.0296997145452175,0.0171027097308358,-0.00382159652722068,0.0632210256176556,0.0825014943805389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20648.Liking for croissant,33284,0.0352270012600889,0.0171041355668213,0.0017028955491191,0.0687511069710587,0.0394698520437317
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20649.Liking for cucumber,33284,-0.00981224947085002,0.017322876987691,-0.0437650883667245,0.0241405894250244,0.571113862954027
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20650.Liking for curry,33284,-0.0330997361520578,0.0172931025674007,-0.0669942171841632,0.000794744880047556,0.0556470201025906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20651.Liking for dairy products,33284,0.0622908897187738,0.0174608967583141,0.0280675320724782,0.0965142473650694,0.000362382517140891
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20652.Liking for dark chocolate,33284,0.0301036834781005,0.01740346026565,-0.00400709864257344,0.0642144655987744,0.083709430030406
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33284,-0.00589770379032409,0.0179970675473069,-0.0411719561830455,0.0293765486023974,0.74314355795408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20654.Liking for dried fruit,33284,0.0149969245642057,0.0172886108033752,-0.0188887526104097,0.048882601738821,0.385721649521176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20655.Liking for eggs,33284,0.0132783539415767,0.0177313519671457,-0.0214750959140289,0.0480318037971822,0.45395972879557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20656.Liking for exercising alone,33284,0.0122922091746973,0.0172091074431662,-0.0214376414139084,0.046022059763303,0.475069794756313
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20657.Liking for exercising with others,33284,0.0143508900534203,0.0172197271116115,-0.0193997750853382,0.0481015551921787,0.404642734100146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33284,-0.0148002898693088,0.0174364003237512,-0.0489756345038611,0.0193750547652435,0.396006896353961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20659.Liking for fatty foods,33284,0.00764164483593595,0.0171896487811136,-0.0260500667750468,0.0413333564469187,0.656656460620737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,33284,0.0153726599207103,0.0189398582381932,-0.0217494622261483,0.0524947820675689,0.417010630889664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20661.Liking for fried chicken,33284,0.00148109117228322,0.0169822271331732,-0.0318040740087362,0.0347662563533026,0.930503240060272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,33284,0.0101051636427368,0.0171468246726197,-0.0235026127155978,0.0437129400010714,0.555654017330607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20663.Liking for fruit,33284,0.0432034413240043,0.0200474562768079,0.00391042702146079,0.0824964556265479,0.0311842258182247
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20664.Liking for garlic,33284,-0.0137635866667588,0.0174237382442552,-0.047914113625499,0.0203869402919814,0.429588098576896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20665.Liking for gherkins,33284,0.00242130606777157,0.0169710413506858,-0.0308419349795726,0.0356845471151157,0.88655185352379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20666.Liking for globe artichoke,33284,0.00432816367714903,0.0171880339480141,-0.0293603828609585,0.0380167102152566,0.801191775485769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20667.Liking for goat's cheese,33284,0.0155126031238717,0.0171228601629172,-0.018048202795446,0.0490734090431895,0.364982483257539
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20668.Liking for going to a cafe,33284,0.0025474304609086,0.0172523750973055,-0.0312672247298103,0.0363620856516274,0.882617002173528
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20669.Liking for going to the gym,33284,0.00609725961299031,0.0170342513543463,-0.0272898730415285,0.0394843922675091,0.720395913332332
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20670.Liking for going to the pub,33284,0.00124591476841603,0.0171179841705004,-0.0323053342057649,0.0347971637425969,0.941979680653251
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20671.Liking for grapefruit,33284,0.00423409674971178,0.0169875064231788,-0.0290614158397187,0.0375296093391422,0.803174993144725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20672.Liking for green olives,33284,0.00238753525647866,0.0172475082571995,-0.0314175809276324,0.0361926514405897,0.889905457387078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20673.Liking for haddock,33284,-0.00402852389580095,0.0175229684688164,-0.0383735420946811,0.0303164943030792,0.818175096525717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20674.Liking for ham,33284,0.00579177099968721,0.0171317510343496,-0.027786461027638,0.0393700030270125,0.735316724719784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20675.Liking for hard cheese,33284,0.0587932276605975,0.0177015085960833,0.0240982708122742,0.0934881845089209,0.000899411738753548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20676.Liking for herring,33284,0.0125185821292966,0.0170037342255916,-0.0208087369528629,0.0458459012114561,0.461613070662847
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20677.Liking for honey,33284,0.0233315128772692,0.017110837740274,-0.0102057290936678,0.0568687548482062,0.172743473255296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33284,-0.013328209482566,0.0170775224254644,-0.0468001534364762,0.0201437344713442,0.435145016820426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20679.Liking for ice cream,33284,0.0205660989457949,0.0171757535045283,-0.0130983779230806,0.0542305758146704,0.231186215756458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20680.Liking for jam,33284,0.0198243206843492,0.0170843624680752,-0.0136610297530781,0.0533096711217766,0.245926280916201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,33284,0.0153406592804154,0.0171936924132898,-0.0183589778496326,0.0490402964104634,0.372296145292294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20682.Liking for lager,33284,-0.0142133142832967,0.0172900048999519,-0.0481017238872025,0.0196750953206091,0.41106849021495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20683.Liking for lamb,33284,-0.00477663350030795,0.0173469783518549,-0.0387767110699436,0.0292234440693277,0.783047468922959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20684.Liking for lemons,33284,-0.00668865300488955,0.0172091862649787,-0.0404186580842478,0.0270413520744687,0.697531436555229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20685.Liking for lentils or beans,33284,-0.0135026548544108,0.0172818216860142,-0.0473750253589987,0.020369715650177,0.434634527624738
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20686.Liking for liver,33284,0.0342339989473181,0.0171909045676127,0.000539825994797183,0.067928171899839,0.0464675086976194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20687.Liking for mackerel,33284,-0.0103247849046137,0.0170218996023815,-0.0436877081252815,0.0230381383160541,0.544159280922256
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20688.Liking for marzipan,33284,-0.00718487361786994,0.0170333306875697,-0.0405702017655066,0.0262004545297667,0.673172080008169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20689.Liking for mayonnaise,33284,0.0192621362301389,0.0170565132552083,-0.0141686297500693,0.0526929022103472,0.258796667800942
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20690.Liking for melon,33284,0.0143732104563334,0.0180654972210083,-0.021035164096843,0.0497815850095098,0.42627628727493
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20691.Liking for milk chocolate,33284,0.0176777812203439,0.017321374191848,-0.0162721121956782,0.0516276746363659,0.307483280930818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20692.Liking for mushrooms,33284,0.0157669464857241,0.0178192480107423,-0.0191587796153308,0.0506926725867789,0.376274216489925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20694.Liking for orange juice,33284,0.0245184291918092,0.0171563469241826,-0.00910801077958864,0.058144869163207,0.153005974960917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20695.Liking for oranges,33284,-0.0188911515786079,0.0175589355538228,-0.0533066652641005,0.0155243621068847,0.282014319713271
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20696.Liking for pasta,33284,0.00213151280713962,0.0172797606440723,-0.031736818055242,0.0359998436695212,0.901830268819816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20697.Liking for pears,33284,0.042656470757744,0.0175907046008313,0.00817868974011457,0.0771342517753735,0.0153306972935373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20698.Liking for pizza,33284,-0.0123977615506588,0.0171388356905484,-0.0459898795041337,0.0211943564028161,0.469470269262226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20699.Liking for plain yogurt,33284,0.0251695511928028,0.0173556289349915,-0.00884748151978046,0.0591865839053861,0.147031585706539
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20700.Liking for plums,33284,0.025172085244043,0.0176312619212689,-0.00938518812164405,0.05972935860973,0.15341471908516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20701.Liking for pollock,33284,0.00979765584453399,0.0170647671153841,-0.0236492877016189,0.0432445993906869,0.565884116993135
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20702.Liking for pork chop,33284,0.00976689897286219,0.0170280409585081,-0.0236080613058138,0.0431418592515382,0.566268447555141
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20703.Liking for porridge,33284,0.033551212561904,0.0176774189917668,-0.00109652866195888,0.068198953785767,0.0577326289786947
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20704.Liking for potato crisps,33284,0.00852909582806176,0.0171864093882897,-0.025156266572986,0.0422144582291095,0.619716438063292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20705.Liking for potatoes,33284,0.00406872878864849,0.0173769045618466,-0.0299900041525709,0.0381274617298679,0.814877242149239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20706.Liking for prawns,33284,0.00259133181788319,0.017419716300684,-0.0315513121314576,0.0367339757672239,0.88174755502998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20707.Liking for raw carrots,33284,-0.00555181154905627,0.0173953761356357,-0.0396467487749022,0.0285431256767897,0.749616957983619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20708.Liking for red meat,33284,-0.00223071236632319,0.01715147379315,-0.0358476010008972,0.0313861762682508,0.8965223050997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20709.Liking for red wine,33284,0.0194559913220982,0.0172163283525383,-0.0142880122488769,0.0531999948930733,0.258469248206318
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33284,0.0093539127090883,0.0180439656342965,-0.0260122599341328,0.0447200853523094,0.604195271397251
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20711.Liking for roast chicken,33284,0.00279477405603139,0.0182600895878771,-0.0329950015362076,0.0385845496482704,0.87835943706051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20712.Liking for salad dressing,33284,-0.00335297565996786,0.0171550795420247,-0.0369769315623362,0.0302709802424005,0.845044476628909
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20713.Liking for salad leaves,33284,-0.000658900762385053,0.0178744529893209,-0.0356928286214539,0.0343750270966838,0.970595307234248
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20714.Liking for salami,33284,-0.00665728308168676,0.0171310783211217,-0.0402341965910853,0.0269196304277118,0.697575136205568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20715.Liking for salmon,33284,-0.0276684176049994,0.0183426089129301,-0.0636199310743423,0.00828309586434349,0.13148204372075
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20716.Liking for salty foods,33284,0.0351816216812827,0.0169905490676992,0.00188014550859227,0.0684830978539732,0.0384197532508392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20717.Liking for salty pretzels,33284,0.0218631961951268,0.0170869584127099,-0.0116272422937846,0.0553536346840383,0.200745769437352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20718.Liking for sardines,33284,0.0223952219019789,0.0170022880082651,-0.0109292625942207,0.0557197063981784,0.187809581838435
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20719.Liking for sausages (meat),33284,0.0127332845744872,0.0171063191854982,-0.0207951010290892,0.0462616701780636,0.456677657737257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,33284,0.0528221808960536,0.0172280972954161,0.0190551101970381,0.0865892515950691,0.00217564218513265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33284,-0.00818274827479498,0.0170705092768667,-0.0416409464574537,0.0252754499078637,0.631701552499033
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20722.Liking for skimmed milk,33284,-0.0138891747073024,0.0170893036209195,-0.0473842098043046,0.0196058603896998,0.416388598927668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20723.Liking for smoked fish,33284,-0.00453633560892312,0.0171048728585608,-0.0380618864117023,0.0289892151938561,0.790856036595157
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20724.Liking for soft cheese,33284,0.0518858242618694,0.0170971234923256,0.0183754622169112,0.0853961863068276,0.0024142103069775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20725.Liking for soy sauce,33284,0.00965148929370817,0.0170946726009115,-0.0238540690040783,0.0431570475914946,0.572366699451778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20726.Liking for soya milk,33284,-0.0115010057800136,0.0172356793841603,-0.0452829373729678,0.0222809258129405,0.504611430313517
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20727.Liking for spicy foods,33284,-0.0320651037322834,0.0171287484102004,-0.0656374506162763,0.00150724315170948,0.0612389589178631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20728.Liking for spinach,33284,0.00380989870924078,0.0173793976690026,-0.0302537207220044,0.0378735181404859,0.826484323369975
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20729.Liking for spirits,33284,0.0121605686462143,0.0170548347344443,-0.0212669074332964,0.0455880447257251,0.475847507965968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20730.Liking for strawberries,33284,0.0149601534402224,0.019546446167605,-0.0233508810482834,0.0532711879287282,0.444075076081539
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33284,0.00894947520395613,0.0177840807517413,-0.0259073230694569,0.0438062734773691,0.614815443607519
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20732.Liking for sweet foods,33284,0.0198678427940795,0.0171638438509467,-0.0137732911537762,0.0535089767419351,0.247082975521718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20733.Liking for taking the stairs,33284,0.0224889659489562,0.0175391319651528,-0.0118877327027432,0.0568656646006556,0.199800367029238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20734.Liking for tea with sugar,33284,-0.002792564212215,0.0229158638604694,-0.047707657378735,0.042122528954305,0.903011389895812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20735.Liking for tea without sugar,33284,0.00578768482916403,0.018404672098033,-0.0302854724829806,0.0418608421413086,0.753172870769927
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,33284,0.00850467693100823,0.0171502756445109,-0.0251098633322332,0.0421192171942496,0.619983273522167
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20737.Liking for tinned tuna,33284,0.00977624055252359,0.0171639895233037,-0.0238651789131517,0.0434176600181989,0.568978069606646
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20738.Liking for turnip (white),33284,0.0109502952348392,0.0170641247167075,-0.0224953892099075,0.0443959796795859,0.521075282270687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20739.Liking for vegetables,33284,0.0361728617243068,0.0200384982413338,-0.0031025948287074,0.075448318277321,0.0710824268490358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20740.Liking for vinegar,33284,-0.0180133294903252,0.0170663085164062,-0.0514632941824813,0.0154366352018309,0.291229872867019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20741.Liking for watching television,33284,-0.0128444745799995,0.0172927659830858,-0.0467382959068476,0.0210493467468486,0.457643279706174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20742.Liking for whisky,33284,0.00911515354018367,0.0182445770946579,-0.0266442175653459,0.0448745246457132,0.617362930913063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20743.Liking for white bread,33284,-0.00321827774675725,0.0170006608561449,-0.0365395730248013,0.0301030175312868,0.849859622718315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20744.Liking for white rice,33284,-0.00527794672984369,0.0171244745052282,-0.0388419167600909,0.0282860233004035,0.757929266805488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20745.Liking for white wine,33284,0.00655487231777118,0.0170621033276468,-0.0268868502044165,0.0399965948399589,0.700856320418899
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33284,0.0317512391061414,0.0172785904586278,-0.00211479819276907,0.0656172764050518,0.0661541105555031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20747.Liking for whole milk,33284,0.0137459554736378,0.0170087350135718,-0.0195911651529629,0.0470830761002384,0.41901430792283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,33284,0.0268049427348245,0.018107796031197,-0.00868633748632159,0.0622962229559706,0.13882931741489
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20749.Liking for working up a sweat,33284,0.000803680962811832,0.0170899758849246,-0.0326926717716404,0.0343000336972641,0.962493208035169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21001.Body mass index (BMI),48117,0.129630010360913,0.0276993226420736,0.0753393379824489,0.183920682739377,2.88605823278223e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21002.Weight,48124,0.0113985749960814,0.0172330630146513,-0.0223782285126352,0.045175378504798,0.508338932841956
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32372,-0.0040657397231374,0.0121049866101255,-0.0277915134789835,0.0196600340327086,0.736975438525216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32801,0.0068014241840141,0.0179835317028188,-0.0284462979535108,0.042049146321539,0.705289478262237
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32815,-0.0109406067875312,0.0188282517650964,-0.0478439802471202,0.0259627666720578,0.561206273404632
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32816,-0.00527910214978813,0.0188496644097599,-0.0422244443929176,0.0316662400933413,0.779435749864821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21040.Satisfaction with bowel habits,32768,-0.0217213706962632,0.0175520063578995,-0.0561233031577462,0.0126805617652198,0.215920368068877
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32756,-0.0192320054705845,0.0182877369710329,-0.055075969933809,0.0166119589926399,0.292998149550579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,32766,-0.00752819207657512,0.0188257202043495,-0.0444266036771002,0.0293702195239499,0.689248797373568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21043.Least number of times bowels opened per week,32686,-0.0117005752878394,0.0185765248514294,-0.0481105639966412,0.0247094134209623,0.528804885232345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21044.Average number of times bowels opened per day,32734,-0.0199277652141868,0.0212784176970882,-0.0616334639004796,0.021777933472106,0.349030399666345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32818,-0.00140910946684064,0.0189278676860849,-0.038507730131567,0.0356895111978857,0.940657059507211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32813,0.00321941339733271,0.0191386573760198,-0.0342923550596661,0.0407311818543316,0.866418039521326
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32816,-0.0413385062836911,0.0221205674365257,-0.0846948184592814,0.00201780589189924,0.0616881603247677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32815,0.010602842841722,0.0198465328602533,-0.0282963615643745,0.0495020472478185,0.5931886155025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32812,0.0256074542583833,0.0295955921320787,-0.0323999063204908,0.0836148148372575,0.386928862627535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32813,0.00918294833393715,0.0217849757429387,-0.0335156041222227,0.051881500790097,0.673381376392892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32813,0.109090733583539,0.0553373229989658,0.000629580505565885,0.217551886661512,0.0487136799872355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32818,0.019358971337445,0.0206895124949151,-0.0211924731525886,0.0599104158274785,0.349459797053355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32816,0.00726176058729584,0.0217456537259567,-0.0353597207155793,0.049883241890171,0.738432618722296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32586,-0.0127430767511214,0.0193137148270621,-0.0505979578121631,0.0251118043099202,0.509404600299447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32814,0.027274264422555,0.0193870431200464,-0.0107243400927358,0.0652728689378459,0.159515117519474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32815,0.0237015081489263,0.0257072743254589,-0.0266847495289732,0.0740877658268258,0.356567324851269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32818,0.011276296990364,0.0189161961143725,-0.025799447393806,0.048352041374534,0.551112106286597
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32817,-0.0248125861166299,0.0189776085648442,-0.0620086989037246,0.0123835266704647,0.191090287525696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X21100.Water hardness (USGS classification),48001,0.00648962705641423,0.0113202742364496,-0.0156981104470269,0.0286773645598554,0.566464173108419
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,44832,-0.00355648698754439,0.00884799861961255,-0.020898564281985,0.0137855903068962,0.687722215970134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2149.Lifetime number of sexual partners,43523,-0.00362493400763271,0.0127376973966422,-0.0285908209050515,0.0213409528897861,0.775966614599659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22032.IPAQ activity group,42741,-0.00847170554446895,0.0126676304439009,-0.0333002612145146,0.0163568501255767,0.50365194056318
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22033.Summed days activity,43334,-0.00664222339379731,0.00837991496417588,-0.023066856723582,0.00978240993598743,0.4279998089905
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22034.Summed minutes activity,42741,0.000782170167015573,0.00842906244991773,-0.0157387922348232,0.0173031325688543,0.926067881075286
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22037.MET minutes per week for walking,41836,-0.00678053892235974,0.00858344404821553,-0.0236040892568622,0.0100430114121427,0.429564526118889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22038.MET minutes per week for moderate activity,42741,0.00759247504811684,0.00832792171651066,-0.00873025151624405,0.0239152016124777,0.361944445607262
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,42741,0.000310335531958393,0.0126452864326531,-0.0244744258760416,0.0250950969399584,0.980420871319023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,41836,-0.00166356078329468,0.00874420351383868,-0.0188021996704185,0.0154750781038291,0.84911759845492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,44880,-0.00285777081591909,0.00793730985168564,-0.0184148981252229,0.0126993564933848,0.718818891369989
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X22501.Year ended full time education,30190,0.0583513375632156,0.0383068332299524,-0.016730055567491,0.133432730693922,0.127748315409504
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X22506.Tobacco smoking,30157,0.0849599006084322,0.0472633513048489,-0.00767626794907172,0.177596069165936,0.072295644381894
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46604,-0.000285330236479988,0.0267237623709164,-0.0526639044834762,0.0520932440105162,0.991481225873944
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23098.Weight,47759,0.0142622938324519,0.017371803626504,-0.0197864412754959,0.0483110289403998,0.411653253676608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23099.Body fat percentage,47760,0.050011320216416,0.0177906164838842,0.0151417119080028,0.0848809285248291,0.00494126165158521
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23100.Whole body fat mass,47754,0.0437080555544269,0.017060643326071,0.0102691946353277,0.0771469164735261,0.0104156690803589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23101.Whole body fat-free mass,47759,-0.0137699627346519,0.0142608170471996,-0.0417211641471632,0.0141812386778594,0.334264299986209
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23102.Whole body water mass,47759,-0.0139339235168185,0.0143110692696052,-0.0419836192852446,0.0141157722516077,0.330242159251608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23104.Body mass index (BMI),47759,0.138156845939036,0.028058553140542,0.0831620817835733,0.193151610094498,8.54264464224069e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23105.Basal metabolic rate,47757,-0.0100736916692139,0.0155456242088357,-0.0405431151185319,0.020395731780104,0.516986042740655
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23106.Impedance of whole body,47753,0.0160913753093119,0.0116456084143115,-0.0067340171827386,0.0389167678013624,0.16706024951641
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23107.Impedance of leg (right),47756,0.0599861215893369,0.0095749729576887,0.041219174592267,0.0787530685864067,3.79622183989905e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23108.Impedance of leg (left),47755,0.055316620768251,0.00946735533841621,0.0367606043049553,0.0738726372315468,5.19884839297255e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23109.Impedance of arm (right),47748,-0.0214368638083888,0.0116787867785522,-0.0443272858943511,0.00145355827757352,0.0664386663620879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23110.Impedance of arm (left),47754,-0.0221340637850491,0.0116989923612546,-0.0450640888131081,0.000795961243009929,0.0585082617197058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23111.Leg fat percentage (right),47755,0.15964112208246,0.0280716268648427,0.104620733427369,0.214661510737552,1.30898207890469e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23112.Leg fat mass (right),47754,0.180898727629434,0.0322340180012395,0.117720052347005,0.244077402911864,2.02222704506098e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23113.Leg fat-free mass (right),47754,-0.0608306210661007,0.0145172931954789,-0.0892845157292394,-0.032376726402962,2.79712845013523e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23114.Leg predicted mass (right),47753,-0.0611142309629847,0.0145768372838883,-0.0896848320394057,-0.0325436298865637,2.76844691696805e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23115.Leg fat percentage (left),47750,0.155831625502541,0.0289764307378953,0.099037821256266,0.212625429748816,7.60955925471373e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23116.Leg fat mass (left),47750,0.163281858557047,0.0323862721628743,0.0998047651178135,0.226758951996281,4.64872427857841e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23117.Leg fat-free mass (left),47748,-0.051209541944927,0.0148754740343647,-0.0803654710522819,-0.0220536128375722,0.000577272446533783
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23118.Leg predicted mass (left),47747,-0.0526640493942059,0.0149355876248882,-0.0819378011389867,-0.0233902976494251,0.000422572526849367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23119.Arm fat percentage (right),47747,0.0475689721905107,0.0196917247217709,0.00897319173583971,0.0861647526451817,0.0157133551759815
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23120.Arm fat mass (right),47745,0.0494876343731865,0.0177811989797943,0.0146364843727896,0.0843387843735833,0.00538782923371757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23121.Arm fat-free mass (right),47746,0.00914161586629687,0.013903442489354,-0.0181091314128369,0.0363923631454306,0.510861232203847
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23122.Arm predicted mass (right),47745,0.00967463610282957,0.0138882592808195,-0.0175463520875766,0.0368956242932358,0.486056740748544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23123.Arm fat percentage (left),47743,0.0401152666159005,0.0220995590206997,-0.00319986906467087,0.0834304022964719,0.0695050127220173
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23124.Arm fat mass (left),47743,0.0576559767309247,0.0182412032414513,0.0219032183776801,0.0934087350841693,0.00157562225307405
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23125.Arm fat-free mass (left),47743,0.0194220857431049,0.014970306338926,-0.00991971468119009,0.0487638861673998,0.194515394884825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23126.Arm predicted mass (left),47741,0.0200759119419691,0.0150054668069998,-0.00933480299975046,0.0494866268836887,0.180939973618549
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23127.Trunk fat percentage,47740,0.0154227321731449,0.0112375735346903,-0.00660291195484808,0.0374483763011378,0.16994424234562
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23128.Trunk fat mass,47736,0.0165797773001542,0.0129762641447783,-0.00885370042361117,0.0420132550239196,0.201367838718296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23129.Trunk fat-free mass,47732,0.00573700992740645,0.0133101390008899,-0.0203508625143377,0.0318248823691506,0.666453786686752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23130.Trunk predicted mass,47729,0.00718569145652308,0.0133397521444652,-0.0189602227466288,0.033331605659675,0.590121427199889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23400.Total Cholesterol,37714,0.127254918989278,0.0100003923302703,0.107654150021948,0.146855687956608,7.05556414073227e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37714,0.140479518405587,0.00964321259599191,0.121578821717443,0.159380215093731,1.05244068715502e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37714,0.145062870723395,0.00962524972328416,0.126197381265758,0.163928360181032,6.62134946691965e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23403.VLDL Cholesterol,37714,0.159783725009062,0.00942399954714691,0.141312685896654,0.17825476412147,8.30078934293496e-64
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37714,0.117073836267916,0.00967211404778884,0.0981164927342495,0.136031179801582,1.50651547409752e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23405.LDL Cholesterol,37714,0.130891985039772,0.0096576486336737,0.111962993717771,0.149820976361772,1.43444274467854e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23406.HDL Cholesterol,37714,-0.0137623260465269,0.0112907617994652,-0.0358922191734787,0.00836756708042494,0.222903275509928
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23407.Total Triglycerides,37714,0.193702014074602,0.0101834183436748,0.173742514121,0.213661514028205,1.29960885205487e-79
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,37714,0.188994410624831,0.0101998960554544,0.16900261435614,0.208986206893521,1.08339997380085e-75
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23409.Triglycerides in LDL,37714,0.175327370899848,0.0101624965896589,0.155408877584116,0.195245864215579,5.62704177065941e-66
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23410.Triglycerides in HDL,37714,0.164173004056773,0.00961809022963031,0.145321547206698,0.183024460906848,1.23168438339025e-64
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37714,0.150728111201618,0.0101801956840613,0.130774927660858,0.170681294742378,3.30867029501602e-49
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,37714,0.17840282980666,0.00969651585818359,0.15939765872462,0.1974080008887,1.14076928729411e-74
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23413.Phospholipids in LDL,37714,0.127592494398693,0.00958596995370545,0.108803993289431,0.146380995507956,3.64750738356747e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23414.Phospholipids in HDL,37714,0.0395831829572149,0.0109164527278178,0.0181869356106919,0.0609794303037378,0.000288911220314379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,37714,0.121689352126851,0.01004228533447,0.10200647287129,0.141372231382412,1.281268015636e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37714,0.149098291464381,0.00937509984764788,0.130723095762991,0.167473487165771,1.98520879600795e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37714,0.140806084903728,0.00962721690457565,0.12193673977076,0.159675430036697,4.54844245492861e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37714,-0.0234557283953307,0.0112126489891726,-0.045432520414109,-0.00147893637655234,0.0364665274105954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23419.Total Free Cholesterol,37714,0.138323433363814,0.00989428936505064,0.118930626208314,0.157716240519313,4.23609717318853e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37714,0.172812357827722,0.00958410119242575,0.154027519490568,0.191597196164877,7.97846057949295e-72
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,37714,0.100088744696663,0.00976694156720236,0.0809455392249461,0.119231950168379,1.49612782025941e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,37714,0.0192434117337136,0.011331843404628,-0.0029670013393572,0.0414538248067844,0.0894988860325798
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37714,0.170893738892108,0.00990870966870557,0.151472667941445,0.190314809842771,6.18350406704387e-66
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,37714,0.188096239416144,0.0098888646496202,0.168714064702889,0.2074784141294,1.30689060854778e-79
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23425.Total Lipids in LDL,37714,0.135987825324776,0.00963111203845671,0.1171108457294,0.154864804920151,6.08105591110863e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23426.Total Lipids in HDL,37714,0.0287894870774065,0.0110612242540381,0.00710948753949171,0.0504694866153213,0.00925850592962031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37714,0.0984302700931343,0.0103057902777115,0.0782309211488199,0.118629619037449,1.50718173291221e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,37714,0.171314953954505,0.00955183788513248,0.152593351699645,0.190036556209364,4.31545851518196e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,37714,0.131016969281934,0.0095548700764581,0.112289423932076,0.149744514631792,1.67554156905517e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,37714,0.0790774073019475,0.0103391333968542,0.0588127058441132,0.0993421087597818,2.17557045707817e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37714,0.175096208006345,0.0107968276468321,0.153934425818554,0.196257990194136,1.39013502102663e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37714,-0.0524341769026746,0.00992715703130738,-0.0718914046840371,-0.0329769491213122,1.29877739060114e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37714,-0.101068857374618,0.0117889940509946,-0.124175285714568,-0.0779624290346688,1.11747586121118e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23434.Phosphoglycerides,37701,0.149060402606644,0.0102425661147215,0.12898497302179,0.169135832191499,1.30114648058756e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37701,0.157438591630376,0.0108767558950964,0.136120150075987,0.178757033184765,4.00105944416697e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23436.Total Cholines,37701,0.142208379768422,0.0102789788260158,0.122061581269431,0.162355178267413,3.13615329115952e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23437.Phosphatidylcholines,37701,0.136514640546569,0.0102893523001825,0.116347510038211,0.156681771054927,6.41537937112674e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23438.Sphingomyelins,37700,0.106763008132957,0.0103587691302229,0.0864598206377198,0.127066195628194,8.16868688042665e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23439.Apolipoprotein B,37714,0.13492383822916,0.00954684796359696,0.11621201622051,0.15363566023781,5.05762816268563e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23440.Apolipoprotein A1,37714,0.0533230492377091,0.0107049896871076,0.0323412694509783,0.07430482902444,6.40066770282748e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37714,0.0908128277557834,0.00968302357513076,0.0718341015485271,0.10979155396304,7.7584981331081e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23442.Total Fatty Acids,37701,0.198828599318941,0.0101858514961359,0.178864330386515,0.218792868251368,1.10554998742573e-83
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23443.Degree of Unsaturation,37701,-0.0940343266889555,0.0107537862937426,-0.115111747824691,-0.0729569055532201,2.51188879314044e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37701,0.0664473831078042,0.0100613456950443,0.0467271455455174,0.0861676206700911,4.14850992817812e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37701,0.161861459937278,0.00989503933242611,0.142467182845723,0.181255737028834,1.46513540941952e-59
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37701,0.156077866012844,0.00999505983036899,0.136487548745321,0.175668183280368,1.74548936924164e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37701,0.210017022585785,0.0104401140511126,0.189554399045604,0.230479646125965,1.11332782729107e-88
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,37701,0.204406320126451,0.0103950650234325,0.184031992680524,0.224780647572379,7.11477924841177e-85
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23449.Linoleic Acid,37701,0.157879811101414,0.00979572326125072,0.138680193509363,0.177079428693466,6.85259266045278e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,37701,0.0211013383054875,0.0105902911899233,0.000344367573237841,0.0418583090377372,0.0463348123541949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37701,-0.0278827457204875,0.0100360778585419,-0.0475534583232297,-0.00821203311774537,0.00547292514917647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37701,-0.157458468375982,0.0112388441464624,-0.179486602903048,-0.135430333848915,2.79407089958868e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37701,-0.174808969990789,0.0112402593936988,-0.196839878402438,-0.152778061579139,4.62812367662312e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37701,0.159395229339316,0.0110935686124498,0.137651834858915,0.181138623819718,1.82869437648795e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37701,0.0912081802781422,0.0104955541992653,0.0706368940475822,0.111779466508702,4.03981078397256e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37701,-0.0368244673204723,0.0108585838661503,-0.0581072916981269,-0.0155416429428177,0.000697709626684219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37701,-0.103316063359219,0.010665088570686,-0.124219636957763,-0.082412489760674,4.04207341830827e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37701,-0.17500806107347,0.011194832510179,-0.196949932793421,-0.153066189353519,1.33445235171737e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37699,-0.00620900533917636,0.0100034481779902,-0.0258157637680371,0.0133977530896844,0.534816585164835
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23460.Alanine,37708,0.0851938390142582,0.0096625142084074,0.0662553111657797,0.104132366862737,1.32151999140035e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23461.Glutamine,37671,-0.094447456275028,0.00972179906658087,-0.113502182445527,-0.0753927301045295,3.08792180959467e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23462.Glycine,37697,0.0324654541675187,0.00927836574198461,0.0142798573132289,0.0506510510218085,0.00046845445898116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23463.Histidine,37695,0.0506508087528118,0.00950352747182137,0.0320238949080419,0.0692777225975817,9.99966906634191e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37705,0.0839133392893624,0.00970402160990541,0.0648934569339478,0.102933221644777,5.87519088805913e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23465.Isoleucine,37711,0.0618975230609933,0.00952401530127776,0.0432304530704889,0.0805645930514978,8.36922522058567e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23466.Leucine,37712,0.0779587973568625,0.00970118616139793,0.0589444724805225,0.0969731222332024,1.00622523625985e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23467.Valine,37705,0.0885095698944237,0.00978662705467123,0.0693277808672681,0.107691358921579,1.71903761391558e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23468.Phenylalanine,37710,0.0267032027498585,0.00950171808007802,0.00807983531290556,0.0453265701868114,0.00495593900098221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23469.Tyrosine,37695,0.0444306235532268,0.00958245847825045,0.0256490049358559,0.0632122421705977,3.57464750071768e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23470.Glucose,37687,0.026310787362008,0.0101308391658843,0.00645434259687487,0.0461672321271412,0.00941189761920627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23471.Lactate,37685,0.130299235406501,0.00945236812915345,0.11177259387336,0.148825876939641,6.22592465018712e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23472.Pyruvate,37673,0.0299768656836888,0.00974092962553503,0.0108846436176402,0.0490690877497375,0.0020923271627768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23473.Citrate,37712,0.0546720175633986,0.00967836972334857,0.0357024129056354,0.0736416222211618,1.64810484377145e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,37552,0.00982445771056487,0.00917479635917941,-0.00815814315342678,0.0278070585745565,0.284274890625961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23475.Acetate,37704,-0.0995209025890356,0.0097822296455985,-0.118694072694409,-0.0803477324836626,3.19134174426743e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23476.Acetoacetate,37713,0.0286926011095348,0.00945312766234794,0.0101644708913329,0.0472207313277368,0.00240802727865322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23477.Acetone,37713,-0.0788870984515286,0.00949181583147408,-0.0974910574812178,-0.0602831394218394,1.04009460278994e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23478.Creatinine,37320,0.0678283957831388,0.0114094882770327,0.0454657987601547,0.0901909928061229,2.83772869716039e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23479.Albumin,37712,0.0783118410734961,0.00976795515310038,0.0591666489734193,0.0974570331735728,1.17179405889857e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,37714,0.206646499834226,0.0103288450623883,0.186401963511945,0.226891036156507,9.43081141872406e-88
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37714,0.171756081537351,0.0103375963845519,0.151494392623629,0.192017770451073,2.2727777980285e-61
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37714,0.164909247527269,0.0103401506619342,0.144642552229878,0.18517594282466,9.83200343868414e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37714,0.166800174368691,0.0101916960133841,0.146824450182458,0.186775898554924,1.27727543928166e-59
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37714,0.176555172107531,0.0101594469252602,0.156642656134021,0.196467688081041,6.61308618107763e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37714,0.17814938075328,0.0100721733068784,0.158407921071798,0.197890840434762,3.2694181187493e-69
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37714,0.170836073753326,0.0102279283585959,0.150789334170478,0.190882813336174,5.36161094742948e-62
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37714,0.152436457229629,0.0104267240802255,0.132000078032387,0.172872836426871,4.96424251415569e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37714,0.185548372497871,0.0101025711475785,0.165747333048617,0.205349411947125,2.03532542042119e-74
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37714,0.183845501490168,0.0101290997027824,0.163992466072714,0.203698536907621,9.68474143214109e-73
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37714,0.180071509876949,0.0100545420774807,0.160364607405086,0.199778412348811,6.78950957820572e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37714,0.175383419645857,0.00976783343317831,0.156238466116827,0.194528373174886,3.04111670128493e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37714,0.166921249442895,0.00956653249581124,0.148170845751105,0.185671653134685,1.99940438528914e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37714,0.178795390560739,0.00998532704013044,0.159224149562083,0.198366631559394,7.23923932937357e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37714,0.180733418719487,0.0102543275003465,0.160634936818808,0.200831900620166,9.59219180321255e-69
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37714,0.185295585942693,0.0100119524595437,0.165672159121987,0.204919012763398,1.60226320404092e-75
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37714,0.183036862710299,0.0099915458812316,0.163453432783085,0.202620292637513,4.75354119603312e-74
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37714,0.179930683198063,0.0099419705105015,0.16044442099748,0.199416945398646,2.44225052061185e-72
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37714,0.175611687728593,0.00965919093269733,0.156679673500507,0.19454370195668,5.62569319896996e-73
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37714,0.16505554800583,0.00943550795774711,0.146561952408645,0.183549143603014,9.31777345419954e-68
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37714,0.183482524229435,0.00990203410879135,0.164074537376203,0.202890511082666,1.06919788220546e-75
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37714,0.181004057386655,0.0101506180414918,0.161108846025331,0.200899268747979,2.6429838339676e-70
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37714,0.163192881908891,0.00949717187254901,0.144578425038695,0.181807338779087,1.80808264835835e-65
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37714,0.173775832620057,0.00959066803644064,0.154978123268633,0.19257354197148,1.67806414727272e-72
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37714,0.159709014987488,0.00947583057753432,0.14113638705552,0.178281642919455,4.4136437837863e-63
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37714,0.121302609133028,0.00958294698633562,0.10252003303981,0.140085185226246,1.63923463395186e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37714,0.0956186962137416,0.00976801882424559,0.0764733793182202,0.114764013109263,1.4973166832095e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37714,0.147858581331066,0.0094636877195758,0.129309753400698,0.166407409261435,1.53487029655956e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37714,0.187777929897344,0.00994513836780669,0.168285458696443,0.207270401098245,1.73096885795499e-78
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37714,0.171718919520345,0.00956418249593834,0.152973121828306,0.190464717212384,3.08564275056789e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37714,0.173513674041797,0.00950579930742753,0.154882307399239,0.192145040684355,1.54032532970368e-73
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37714,0.15937161944242,0.00940041137132237,0.140946813154628,0.177796425730212,8.48165870071877e-64
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37714,0.145327964461957,0.0093051725445916,0.127089826274557,0.163566102649356,1.67839637639688e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37714,0.144753563040175,0.00925171055641072,0.126620210349609,0.16288691573074,1.08739592303166e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37714,0.143168316571905,0.00943256700878637,0.124680485234684,0.161656147909127,1.33958850820326e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37714,0.175945933017367,0.00986882411686999,0.156603037748301,0.195288828286432,2.80306334217875e-70
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37714,0.13961077618071,0.00964968968983896,0.120697384388625,0.158524167972794,4.41105732482378e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37714,0.140157340296088,0.00964954244580359,0.121244237102313,0.159070443489863,1.95199799088224e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37714,0.133825486971992,0.00964181142845058,0.114927536572228,0.152723437371755,1.69353756338615e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37714,0.117305216190858,0.00984006778140114,0.0980186833393119,0.136591749042404,1.34685316523928e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37714,0.110296297601704,0.00992052759614591,0.090852063513258,0.12974053169015,1.37183389810923e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37714,0.129610439523669,0.00968257341254218,0.110632595635086,0.148588283412252,1.33992548692891e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37714,0.158956100420513,0.00981986091803537,0.139709173021164,0.178203027819862,2.24916203601313e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,37714,0.109595536845622,0.00971131855410298,0.0905613524795806,0.128629721211664,2.11086274779559e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23524.Total Lipids in IDL,37714,0.115207901128427,0.00998501738886334,0.0956372670462545,0.134778535210599,1.18764120672638e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23525.Phospholipids in IDL,37714,0.112765775146144,0.0100140524002368,0.0931382324416799,0.132393317850608,2.78365422426465e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23526.Cholesterol in IDL,37714,0.102558236827937,0.010013845348962,0.0829310999439709,0.122185373711902,1.59213126026928e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37714,0.104728838007175,0.00999485183669452,0.0851389284072541,0.124318747607097,1.3682968894441e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,37714,0.0934813075066579,0.0100554511147729,0.073772623321703,0.113189991691613,1.67403618767567e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23529.Triglycerides in IDL,37714,0.155571871933537,0.00996331262619336,0.136043779186198,0.175099964680876,1.77142509693359e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37714,0.118176412011613,0.00961803887213222,0.0993250558222343,0.137027768200993,1.63962083517309e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,37714,0.129137764496148,0.00971914008900793,0.110088249921692,0.148187279070603,4.9661203057275e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,37714,0.125162562081772,0.00967389882282745,0.106201720389031,0.144123403774514,4.65672257152153e-38
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,37714,0.12261393203904,0.00975703769898702,0.103490138149026,0.141737725929055,5.16099054561202e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37714,0.130034693683484,0.00970994103026549,0.111003209264164,0.149066178102804,1.23786641917503e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37714,0.0987555768406078,0.00987825648691462,0.0793941941262551,0.11811695955496,1.89648560652269e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,37714,0.165099544900142,0.0100920486097996,0.145319129624934,0.184879960175349,1.42764600261505e-59
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37714,0.147415107880116,0.00950929478661947,0.128776890098342,0.16605332566189,9.91536899698837e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37714,0.148998221159938,0.00955104279995605,0.130278177272025,0.167718265047852,2.20636148466545e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37714,0.139510085872772,0.00949031692974621,0.12090906469047,0.158111107055075,1.54652341334479e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37714,0.145509345281117,0.00955595219285526,0.126779678983121,0.164239011579114,6.42105919407017e-52
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37714,0.157052195806601,0.00957793935293783,0.138279434674843,0.175824956938359,7.74987513805594e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37714,0.108076812484747,0.0095985472760804,0.0892636598236297,0.126889965145865,2.81664749875503e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37714,0.182165545787969,0.0102225270631716,0.162129392744153,0.202201698831786,3.24864959617086e-70
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37714,0.136661617550005,0.00948604192677867,0.118068975373519,0.155254259726491,1.05867248416193e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,37714,0.130532180701765,0.00958823037990742,0.111739249157147,0.149325112246384,6.34179026994223e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,37714,0.0965056271227361,0.00958056239789509,0.0777277248228617,0.11528352942261,8.84923767019118e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,37714,0.13115889828292,0.00955823604270002,0.112424755639228,0.149893040926612,1.46213810935804e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37714,0.148644515602653,0.00960250865407693,0.129823598640662,0.167465432564644,1.39732998672124e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37714,0.0782203615932746,0.00955557541227895,0.0594914337852079,0.0969492894013414,2.94961871287919e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,37714,0.192579555796868,0.0102962202439186,0.172398964118787,0.212760147474948,4.49913805600415e-77
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37714,-0.0547589892130236,0.0112223721492264,-0.0767548386255073,-0.0327631398005399,1.07619277244065e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37714,-0.0836276190102278,0.0112756074842561,-0.10572780967937,-0.0615274283410859,1.27379002690232e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37714,-0.0903885371774912,0.0112671573595621,-0.112472165602233,-0.0683049087527495,1.12451252245799e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37714,-0.0893699044903334,0.0112091369894308,-0.111339812989618,-0.067399995991049,1.67548587753166e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37714,-0.0902657036404924,0.0113939442670029,-0.112597834403818,-0.0679335728771667,2.51755720200318e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37714,-0.0805810990058704,0.0104266160292163,-0.101017266423134,-0.0601449315886064,1.16715591885831e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37714,0.133051568163302,0.0100227010353242,0.113407074134067,0.152696062192538,5.81192542643979e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37714,-0.0662516270759214,0.0118963272207733,-0.089568428428637,-0.0429348257232057,2.61063661613266e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,37714,-0.0676136508534675,0.0118297502933257,-0.0907999614283858,-0.0444273402785491,1.1169704983762e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,37714,-0.0574250376973997,0.0116745842522488,-0.0803072228318074,-0.0345428525629921,8.81168648944321e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,37714,-0.0900491661771639,0.0118269891722084,-0.113230064954692,-0.0668682673996354,2.83965743764754e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37714,-0.0956271556129791,0.0117886163531096,-0.118732843665074,-0.0725214675608843,5.4225833110248e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37714,-0.0688046795798318,0.011819960854345,-0.0919718028543481,-0.0456375563053155,5.98288516890949e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,37714,0.108738357769769,0.00991372816127777,0.0893074505736648,0.128169264965874,7.13874046734137e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37714,0.0467669844928182,0.0106125987158173,0.0259662910098164,0.0675676779758201,1.057609130078e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37714,0.0572957181379361,0.0105095287930639,0.0366970417035308,0.0778943945723414,5.07581432733034e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37714,0.0703955459620867,0.0104298924922366,0.049952956677303,0.0908381352468705,1.54626062161417e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37714,0.0179248698965265,0.0106630998566046,-0.00297480582241856,0.0388245456154715,0.0927828365828815
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37714,0.010936535015909,0.0106083269833479,-0.00985578587145288,0.0317288559032709,0.302588359185851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37714,0.0451503193294834,0.0107953691945425,0.02399139570818,0.0663092429507868,2.90330093108018e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37714,0.161951819986162,0.00953158444039044,0.143269914482997,0.180633725489327,4.54828507029983e-64
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37714,0.130234293281324,0.00945513137459368,0.11170223578712,0.148766350775527,7.21418711940274e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,37714,0.150112055791054,0.00954011080540237,0.131413438612465,0.168810672969643,2.75823684435049e-55
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,37714,0.149003869310447,0.00964449000074128,0.130100668908994,0.1679070697119,2.21229497482168e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,37714,0.115514511035897,0.00949006767309622,0.0969139783966287,0.134115043675166,6.63265290516384e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37714,0.0979948029688186,0.00939336903334041,0.0795837996634714,0.116405806274166,2.21275318824014e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37714,0.151065566331218,0.00981922484695021,0.131819885631195,0.17031124703124,5.94205984842226e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,37714,0.17932242577546,0.00983260403422884,0.160050521868371,0.198594329682548,2.04673685935243e-73
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,0.0428639948081193,0.00902918256523985,0.0251667969802492,0.0605611926359894,2.08457321519684e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,-0.00277242686045989,0.009443063880493,-0.0212808320662262,0.0157359783453064,0.769073022749125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,0.0175572959646923,0.00920555339278506,-0.000485588685166443,0.035600180614551,0.0565109860193674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,-0.0374422130319767,0.00962607316051666,-0.0563093164265894,-0.0185751096373641,0.000100900412100759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,-0.0157793769639631,0.00915041904909644,-0.0337141983001921,0.00215544437226597,0.0846525261694704
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37515,0.051199855577145,0.0088881119240256,0.0337791562060548,0.0686205549482351,8.57620174902202e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37515,-0.0882534055207947,0.0101237236278498,-0.10809590383138,-0.0684109072102091,3.18473787201499e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37515,-0.090184897357074,0.0101459893834612,-0.110071036548658,-0.07029875816549,6.98345843785367e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37515,-0.0591653761715615,0.00958524987215886,-0.0779524659209929,-0.0403782864221301,6.91887796658295e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37515,0.0563677942520635,0.00973394554424501,0.0372892609853433,0.0754463275187837,7.1643696253379e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37709,0.113143458028736,0.00948441706755595,0.0945540005763264,0.131732915481146,1.2216301839034e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37709,-0.00849163128389483,0.00937282070179546,-0.0268623598594139,0.00987909729162428,0.364960465254883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37709,-0.0385900966240804,0.00983245072741783,-0.0578617000498194,-0.0193184931983414,8.72516432614165e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37709,0.0526425115665851,0.00898526332392001,0.0350313954517019,0.0702536276814684,4.77401447830951e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37709,-0.0423493161609175,0.00882490146008357,-0.0596461230226812,-0.0250525092991537,1.61324698694788e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37714,-0.00757035417284086,0.0098951496296552,-0.0269648474469651,0.0118241391012833,0.444251176118532
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37714,-0.0777553972568942,0.0103461377216683,-0.0980338271913641,-0.0574769673224244,6.03692530580014e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37714,-0.0900049279500674,0.0104255825218427,-0.110439069692879,-0.0695707862072556,6.64710676722979e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37714,-0.0419765072056724,0.0101133962913611,-0.0617987639367401,-0.0221542504746047,3.33698296440432e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37714,0.0624551003007991,0.0102715774982444,0.0423228084042401,0.082587392197358,1.23190672963823e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37714,-0.0509840687943041,0.0100921528672587,-0.0707646884141311,-0.0312034491744772,4.43363348043487e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37714,-0.0330814687763529,0.00983992415545908,-0.0523677201210527,-0.0137952174316531,0.00077608980397135
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37714,-0.015793193768202,0.00956341297379057,-0.0345374831968315,0.00295109566042754,0.0986768969546332
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37714,-0.0539529148145069,0.010121949043534,-0.0737919349398335,-0.0341138946891803,9.96630571851252e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37714,0.0389850582175821,0.0099284041526938,0.0195253860783023,0.0584447303568619,8.65842094084995e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37714,-0.0315784133476796,0.0101379993012935,-0.0514488919782149,-0.0117079347171444,0.00184426691496263
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37714,-0.048360505481716,0.010518777861122,-0.0689773100895152,-0.0277437008739168,4.31457422659655e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37714,-0.0483781158649667,0.0105970623033761,-0.0691483579795838,-0.0276078737503495,5.03413020034808e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37714,-0.0353739763244592,0.0102143993496909,-0.0553941990498532,-0.0153537535990651,0.000535579570492517
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37714,0.0638172387032519,0.0104831252032749,0.0432703133048331,0.0843641641016706,1.1776696128442e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37714,-0.0415079566540479,0.00946927801568838,-0.0600677415647971,-0.0229481717432987,1.17721700093861e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37714,-0.018633672927506,0.0100491107800949,-0.038329930056492,0.00106258420147991,0.0637240314401976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37714,0.00144498606669492,0.0100334365508055,-0.0182205495728839,0.0211105217062738,0.885489183776078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37714,-0.058430308861549,0.0102166783863928,-0.0784549984988788,-0.0384056192242192,1.09394249443064e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37714,0.044267870746032,0.0103610097036006,0.0239602917269748,0.0645754497650891,1.94603268637898e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37714,-0.0419800416725416,0.00944994631725359,-0.0605019364543586,-0.0234581468907246,8.96989409942969e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37714,-0.00776961032227488,0.0104021019207873,-0.028157730087018,0.0126185094424682,0.455120895038883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37714,0.0789926416097202,0.00954401101239601,0.060286380025424,0.0976989031940164,1.38694422775535e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37714,-0.104257360556087,0.0103307001536303,-0.124505532857203,-0.084009188254972,7.30899437700305e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37714,0.0255209521432617,0.0103240104156212,0.0052858917286442,0.0457560125578792,0.0134484132816796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37714,-0.0990490953379975,0.00932009330403686,-0.11731647821391,-0.0807817124620853,2.83201549825542e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37714,0.0420259192474613,0.00959059881626387,0.0232283455675841,0.0608234929273385,1.18503144991128e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37714,0.14027361787455,0.00968257176390502,0.121295777217296,0.159251458531804,3.34477578042252e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37714,-0.144449703824185,0.0105050679122595,-0.165039636932213,-0.123859770716156,9.93322745644754e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37714,0.0163357194106887,0.00996087432967745,-0.00318759427547913,0.0358590330968565,0.101031273422654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37714,-0.172831579351542,0.00943300564108369,-0.191320270408066,-0.154342888295017,4.51832203718989e-74
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37714,0.0885303319001022,0.00961148420627391,0.0696918228558053,0.107368840944399,3.71393796638821e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37714,0.168270965465587,0.00953024168368055,0.149591691765574,0.186950239165601,5.56960108761021e-69
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37714,-0.110509677976415,0.0102941889547793,-0.130686288327782,-0.0903330676250476,8.966307240715e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37714,0.0944423435830113,0.010168884259214,0.0745113304349518,0.114373356731071,1.82410130758792e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37712,-0.105704257861082,0.010932638258211,-0.127132228847175,-0.0842762868749882,4.84282922713705e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37712,0.00671168266560139,0.0109412750631521,-0.0147332164581767,0.0281565817893794,0.539604008216794
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37712,-0.0184079475355081,0.0109761995156812,-0.0399212985862432,0.00310540351522698,0.093550714731684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37712,0.0545476091061003,0.0116840306946438,0.0316469089445985,0.077448309267602,3.06289854949864e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37712,0.183417877843295,0.0108456639491033,0.162160376503053,0.204675379183538,1.70740279165419e-63
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37714,0.104973419856203,0.0113335123628833,0.0827597356249514,0.127187104087454,2.30636702676309e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37714,-0.15665237469479,0.0112740715201964,-0.178749554874375,-0.134555194515205,1.37355635689168e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37714,-0.165014000455751,0.0113645112942909,-0.187288442592561,-0.14273955831894,2.08685254402961e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37714,-0.0452234550144514,0.0110059573160573,-0.0667951313539237,-0.0236517786749792,3.99768271512983e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37714,0.16319467612669,0.0109540788332809,0.141724681613459,0.184664670639921,8.56915195509558e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37714,0.0854341955328742,0.0107112266263639,0.0644401913452009,0.106428199720547,1.63304522231992e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37714,-0.128252772657465,0.0104299890821812,-0.14869555125854,-0.10780999405639,1.45822864481644e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37714,-0.144499907912075,0.0103332941623171,-0.164753164470217,-0.124246651353934,4.01966568589552e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37714,-0.00160580871658167,0.0113105600465479,-0.0237745064078156,0.0205628889746522,0.887102471225551
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37714,0.144197110435494,0.0101336817634633,0.124335094179106,0.164059126691882,1.30184896621734e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37714,-0.00871827103924343,0.00989360847221792,-0.0281097436447906,0.0106732015663037,0.378224276841655
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37714,-0.0808825296729948,0.00993117587586911,-0.100347634389698,-0.0614174249562913,4.15365390981271e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37714,-0.0795577030525152,0.00995857623445864,-0.0990765124720541,-0.0600388936329763,1.47372575365107e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37714,0.00208250957399079,0.0102095781261641,-0.0179282635532908,0.0220932827012724,0.838375332646883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37714,0.137037222597911,0.0101347600443208,0.117173092911043,0.15690135228478,2.19499401263523e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47858,-0.00197524273370663,0.00816667021676023,-0.0179819163585567,0.0140314308911434,0.808885842225309
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47858,-0.00834951758540465,0.00800034557401926,-0.0240301949104824,0.00733115973967309,0.296660621255908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46180,-0.00121712851621283,0.00768950241812575,-0.0162885532557393,0.0138542962233136,0.874234146582358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46180,-0.0102181761460963,0.00840920146085591,-0.0267002110093738,0.00626385871718131,0.22433410765169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46180,-0.0183961260335532,0.00821813076447775,-0.0345036623319296,-0.00228858973517679,0.0251998184384746
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46180,-0.00767442260508432,0.00753988977573468,-0.0224526065655243,0.00710376135535564,0.30876399625005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,47858,-0.0508492877360867,0.0250453595418201,-0.0999381924380541,-0.00176038303411932,0.0423385790241991
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24010.Inverse distance to the nearest road,47858,-0.00386284178170147,0.00715686551222198,-0.0178902981856566,0.0101646146222536,0.589381948542185
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,47858,0.00280531037058705,0.00715239487243086,-0.0112133835793774,0.0168240043205515,0.694899440078047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,47858,-0.0108412470174628,0.00730129144931612,-0.0251517782581224,0.00346928422319684,0.137599773556082
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24013.Total traffic load on major roads,47858,-0.0194617113966506,0.0174324281278002,-0.053629270527139,0.0147058477338377,0.26425876655351
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,47858,-0.0271993802747363,0.0168852521218453,-0.0602944744335531,0.0058957138840804,0.107228850037261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47858,0.00696592256641979,0.00813186905975414,-0.00897254079069832,0.0229043859235379,0.391663638069799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47858,0.0038898370145245,0.00811590337094893,-0.0120173335925354,0.0197970076215844,0.631739820285603
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47858,0.00430156063367217,0.00804100878371309,-0.0114588165824055,0.0200619378497498,0.592687537562328
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47800,0.0271589163782339,0.00790175441312402,0.0116714777285108,0.042646355027957,0.00058905882089775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,47858,-0.015692787411415,0.00721522523611811,-0.0298346288742065,-0.00155094594862348,0.0296434949336014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,47858,-0.0156032995799145,0.00721526202365103,-0.0297452131462705,-0.00146138601355849,0.0305865995287942
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,47858,-0.0157279229473566,0.00721512974734522,-0.0298695772521532,-0.00158626864255996,0.0292782827948793
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47858,-0.015655825296617,0.00721491232861483,-0.0297970534607021,-0.00151459713253197,0.0300224832279031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47858,-0.0156545854140543,0.00721518188970939,-0.0297963419178847,-0.00151282891022391,0.0300416535452377
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45197,0.0010328672365461,0.00844189773057255,-0.0155132523153761,0.0175789867884683,0.902622921850825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45197,-0.011426308048758,0.0076960728662661,-0.0265106108666396,0.00365799476912355,0.137640273557653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",45197,-0.00977768265308937,0.00753633762202654,-0.0245489043922614,0.00499353908608265,0.194506275656167
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45197,-0.00146427417547483,0.00794702255639627,-0.0170404383860115,0.0141118900350619,0.853815656035448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45197,-0.00488256381162619,0.00776954147707661,-0.0201108651066963,0.010345737483444,0.52973335000489
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",45197,-0.00474507263947477,0.00759629484199574,-0.0196338105297864,0.0101436652508369,0.532203598357729
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48001,-0.00866258950728164,0.00796125515459812,-0.024266649610294,0.00694147059573068,0.276564995224898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48001,-0.013573842519856,0.00751214107891601,-0.0282976390345314,0.00114995399481938,0.0707874170723319
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,48001,0.0447676388342396,0.0071348954377953,0.0307832437761608,0.0587520338923184,3.56951479029932e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34078,-0.0134832034065278,0.0186249440577895,-0.0499880937597953,0.0230216869467396,0.469124734515743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2704.Years since last cervical smear test,42463,0.014556737461677,0.0132675751955945,-0.0114477099216882,0.0405611848450421,0.272583335623617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2714.Age when periods started (menarche),47412,0.0146959880025616,0.0113614664806796,-0.00757248629957044,0.0369644623046937,0.19585329326592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2734.Number of live births,48141,0.00988550106038646,0.0108901763533719,-0.0114592445922225,0.0312302467129955,0.364022300568669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2744.Birth weight of first child,43298,0.0066636242784754,0.0121325612748495,-0.0171161958202296,0.0304434443771804,0.58285086896234
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2754.Age at first live birth,40515,-0.00850662547662275,0.00912866841333883,-0.0263988155667669,0.00938556461352135,0.351423763229171
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2764.Age at last live birth,40468,0.00350289433737517,0.00879730524299381,-0.0137398239388927,0.020745612613643,0.690504211053936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2794.Age started oral contraceptive pill,42576,0.000496762290197308,0.00995773210710155,-0.0190203926397217,0.0200139172201163,0.96021291392249
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2804.Age when last used oral contraceptive pill,40893,-0.00649019903352499,0.00866402732452973,-0.0234716925896033,0.0104912945225533,0.453809310149807
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,29299,0.0287151409777954,0.0162192568340778,-0.00307460241699718,0.0605048843725879,0.0767175385860495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33747,0.00118507948848421,0.0199889650816794,-0.0379932920716073,0.0403634510485757,0.952725040586479
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33738,0.0108739686746299,0.0216673185698098,-0.0315939757221973,0.0533419130714571,0.615777639589461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33768,0.00630090217114667,0.0238303495024034,-0.0404065828535639,0.0530083871958573,0.791472461062399
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33729,0.0475522902864838,0.0227333635007426,0.00299489782502822,0.0921096827479393,0.0364888902960265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28739.Difficulty with standing for long periods,33783,-0.0152728506758151,0.0201842732985277,-0.0548340263409293,0.0242883249892991,0.44926620972601
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,33807,0.00489053845181025,0.0218197737081191,-0.0378762180161032,0.0476572949197237,0.822658457871404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28741.Difficulty learning a new task,33711,0.0128601606767037,0.0242243557845197,-0.034619576660955,0.0603398980143624,0.595516543922453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28742.Difficulty with joining in community activities,33466,-0.00303383906533065,0.025686619081128,-0.0533796124643416,0.0473119343336803,0.905983364384903
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,33743,0.00666800508902352,0.0214029436044933,-0.0352817643757834,0.0486177745538305,0.75539244245831
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33798,-0.0543570538947222,0.0315987166920225,-0.116290538611086,0.00757643082164189,0.0854237928945888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29277,-0.0141031282419876,0.0254866581403033,-0.064056978196982,0.0358507217130068,0.580047104117878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2897.Age stopped smoking,29306,0.0167409950841431,0.0166953716459701,-0.0159819333419583,0.0494639235102446,0.31603982105037
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32842,-0.0542180950123907,0.0243714323061782,-0.1019861023325,-0.00645008769228136,0.0261307223834925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32842,0.0554140893504995,0.0259877161995781,0.00447816559932635,0.106350013101673,0.0330096236835733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32842,-0.000304568532653278,0.0871059480877608,-0.171032226784665,0.170423089719358,0.997210261766619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32842,0.026273610446885,0.0930850753994742,-0.156173137336084,0.208720358229854,0.777755918070407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32842,0.0800402746846877,0.0981890194847319,-0.112410203505387,0.272490752874762,0.415000876199093
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32842,0.0870071258276189,0.0787201556601714,-0.067284379266317,0.241298630921555,0.269073759840959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32842,0.0253701803535286,0.0367996960690309,-0.0467572239417719,0.0974975846488291,0.490582616283217
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32842,0.0364204975729995,0.0637866084878248,-0.088601255063137,0.161442250209136,0.568032532558147
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32789,0.00632474477739594,0.0241522177934676,-0.0410136020978006,0.0536630916525924,0.79342802833895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29003.Recent feelings of depression,32777,0.0103392895108995,0.0230213869076361,-0.0347826288280673,0.0554612078498663,0.65335916160514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32794,0.0309694216939921,0.0189159680089061,-0.00610587560346379,0.068044718991448,0.101624218832952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,32802,0.0149620590654072,0.0192843334619483,-0.0228352345200116,0.0527593526508259,0.437850076525907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29006.Recent poor appetite or overeating,32807,-0.0146153783724567,0.0249077940312717,-0.0634346546737492,0.0342038979288357,0.557367786974138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29007.Recent feelings of inadequacy,32764,0.00507248444304137,0.0249744957924996,-0.0438775273102578,0.0540224961963405,0.839056701068317
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29008.Recent trouble concentrating on things,32806,-0.0252993008058768,0.0253771486978133,-0.0750385122535907,0.0244399106418372,0.318826223535058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32795,-0.0246333937210439,0.0454989793388615,-0.113811393225212,0.0645446057831247,0.588242636601231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,32737,0.0528977180925655,0.0505081785913429,-0.0460983119464667,0.151893748131598,0.294987206911112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,31908,0.0124214302518876,0.0467375604156973,-0.079184188162879,0.104027048666654,0.79042388138401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31908,-0.0800802467177581,0.0928960222533297,-0.262156450334284,0.101995956898768,0.38869228437236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31908,-0.00449095974162393,0.0438887791014046,-0.0905129667803769,0.081531047297129,0.918500733045373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31908,-0.258392581576923,0.130063761579116,-0.513317554271991,-0.00346760888185577,0.0469965377650847
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31908,0.00407116907971142,0.0812770673369721,-0.155231882900754,0.163374221060177,0.960052002682625
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31908,-0.0592022301642451,0.0840701683437008,-0.223979760117899,0.105575299789408,0.481330093246508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31908,-0.101412137525929,0.101501045920343,-0.300354187529801,0.0975299124779433,0.317767018761742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31908,0.10511571964525,0.111400077571951,-0.113228432395775,0.323459871686274,0.345411060864452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31908,-0.0700151654787198,0.0836478545810604,-0.233964960457598,0.0939346295001586,0.402606551987968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31908,0.0254691054599373,0.0470628333651061,-0.0667740479356707,0.117712258855545,0.588404942336411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31908,-0.0213020535545986,0.0711318864374802,-0.16072055097206,0.118116443862863,0.764587794989808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31908,-0.0449100454539356,0.109856484019831,-0.260228754132805,0.170408663224934,0.682693405731838
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31908,-0.0358941513263525,0.145025857957831,-0.320144832923702,0.248356530270997,0.804526764626616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31908,0.00207197359526197,0.0961677656303753,-0.186416847040274,0.190560794230797,0.982811159300926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31908,0.233683329625915,0.161267959670349,-0.0824018713279691,0.549768530579798,0.147369150465386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31908,0.0520090759772971,0.148904496313796,-0.239843736797744,0.343861888752338,0.726890419742212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31908,-0.108669983359721,0.0809514236738712,-0.267334773760509,0.0499948070410663,0.179504033763561
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31908,-0.00168973921462757,0.0786656613912287,-0.155874435541436,0.152494957112181,0.982863324057574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31908,-0.104925962031653,0.109379941821796,-0.319310648002374,0.109458723939068,0.33744894471884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,32672,0.0164389774378237,0.0213767410271534,-0.0254594349753969,0.0583373898510443,0.44190809063613
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29059.Recent inability to stop or control worrying,32682,0.0142083153444091,0.0219474870754625,-0.0288087593234974,0.0572253900123156,0.517405537491165
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29060.Recent worrying too much about different things,32676,0.015586637609418,0.020551188040106,-0.0246936909491898,0.0558669661680258,0.448215341154889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29061.Recent trouble relaxing,32682,0.0202987459516845,0.0217270221355693,-0.0222862174340314,0.0628837093374005,0.350195825932988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29062.Recent restlessness,32690,0.0104896717635036,0.0313663258925459,-0.0509883269858865,0.0719676705128937,0.738067675757303
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29063.Recent easy annoyance or irritability,32657,-0.0100714298619578,0.022828268788623,-0.0548148366876589,0.0346719769637434,0.659092598706805
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29064.Recent feelings of foreboding,32650,0.0201063723517454,0.0245986351429389,-0.028106952528415,0.0683196972319057,0.413736455405845
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31908,-0.000263327463780854,0.0468385306579477,-0.0920668475533584,0.0915401926257967,0.995514445837307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31908,0.060093717697589,0.0797765264555444,-0.096268274155278,0.216455709550456,0.451308050534282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31908,0.0335702156853021,0.101315435666023,-0.165008038220103,0.232148469590708,0.740394314548563
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31908,0.07835125826326,0.112086699460473,-0.141338672679267,0.298041189205787,0.484559030044438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31908,-0.0251955564329259,0.0768566055923446,-0.175834503393921,0.12544339052807,0.743052797647744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31908,0.014240064789744,0.0760260551551935,-0.134771003314435,0.163251132893923,0.851426552742899
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31908,-0.0835717605837039,0.0778629637468258,-0.236183169527482,0.0690396483600747,0.28316296666581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31908,0.0435662880099031,0.0703126232067302,-0.0942464534752882,0.181379029495094,0.535534605375525
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31908,-0.136112698416641,0.0946358564865805,-0.321598977130339,0.0493735802970564,0.150397078569922
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29076.Felt loved as a child,32653,0.0286776071954078,0.020156986658428,-0.0108300866551111,0.0681853010459266,0.154857416223992
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29077.Physically abused by family as a child,32667,-0.0432741184325785,0.0282671389139476,-0.0986777107039158,0.0121294738387588,0.125833017348011
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29078.Felt hated by family member as a child,32648,0.0189982883307532,0.0262582724396324,-0.0324679256509263,0.0704645023124328,0.469383394266409
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29079.Sexually molested as a child,32559,0.00729980579072725,0.0332033041914049,-0.0577786704244263,0.0723782820058808,0.82599212270734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,32631,0.0121443710547694,0.0283742360431624,-0.043469131589829,0.0677578736993677,0.668657312677992
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32646,-0.0579853566851204,0.0353819846820504,-0.127334046661939,0.0113633332916984,0.101285306609537
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32583,0.00800050502258428,0.0264203734683869,-0.0437834269754541,0.0597844370206226,0.762038032502635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32648,-0.0201694233965932,0.0294536989596705,-0.0778986733575474,0.037559826564361,0.4934995652131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32608,0.0225487299127871,0.0365034932428804,-0.0489981168432584,0.0940955766688326,0.536780929965159
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32617,-0.00562551278050856,0.0363543990922815,-0.0768801350013803,0.0656291094403631,0.877029402465347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29086.Experienced a violent or sexual assault,32647,-0.032242526288573,0.0339155655395439,-0.098717034746079,0.0342319821689331,0.34179972744383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,32660,-0.01387342246253,0.0242829378203897,-0.0614679805904938,0.0337211356654337,0.567795756161674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29088.Experienced a marital separation or divorce,32660,-0.0169595633224019,0.0216365247923579,-0.0593671519154235,0.0254480252706196,0.433156899052159
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29089.Experienced the death of a spouse or partner,32668,-0.00909453774195143,0.0273715582051406,-0.0627427918240269,0.0445537163401241,0.739699658089173
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32653,0.0408242226936657,0.0275147366998443,-0.0131046612380291,0.0947531066253604,0.137921097101361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,32664,-0.0180340222823232,0.0180386670392276,-0.0533898096792092,0.0173217651145628,0.317464601251864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31584,-0.0301138930854671,0.0222923763895026,-0.0738069508088921,0.013579164637958,0.176782962259132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31601,-0.0447179859953258,0.0228767315349334,-0.0895563798037952,0.000120407813143597,0.0506530951601852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29104.Ever used cannabis,32658,0.00496149980642887,0.0277972238095831,-0.049521058860354,0.0594440584732118,0.858343335135264
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29108.Ever thought that life not worth living,32614,0.0210429652970035,0.0218543851522821,-0.0217916296014695,0.0638775601954765,0.335640526393561
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29109.Ever contemplated self-harm,32641,0.0140272035446109,0.0291125070159816,-0.0430333102067131,0.0710877172959349,0.629941441374387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29111.Ever self-harmed,32655,0.0378368128523901,0.0453144739583515,-0.0509795561059789,0.126653181810759,0.403751631941949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32647,-0.0100301499002344,0.0308455997975253,-0.0704875255033841,0.0504272257029152,0.745058599237227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32507,0.136324900400588,0.0990494717388515,-0.057812064207561,0.330461865008737,0.16875730696545
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32507,0.0496639218633071,0.0783130592628393,-0.103829674291858,0.203157518018472,0.525986816936789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32507,0.109248793261193,0.0791718912091805,-0.0459281135088007,0.264425700031187,0.167657678150495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32507,0.114096822563115,0.103363689245249,-0.088496008357574,0.316689653483804,0.269696162685527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32642,-0.0257647149762781,0.0201395624764877,-0.065238257430194,0.0137088274776378,0.200824660908402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X29153.Pain or discomfort today,32653,0.00297245802493777,0.0192735956980558,-0.0348037895432515,0.0407487055931271,0.87743662918518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29154.Anxiety or depression today,32653,0.021127396937655,0.0232150913593792,-0.0243741821267283,0.0666289760020383,0.362811470365995
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29166.Frequency of confiding in someone close,32447,0.00356727786652595,0.0187579315096301,-0.033198267892349,0.0403328236254009,0.84917732249614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32624,-0.0192716168273121,0.026064441402308,-0.0703579219758358,0.0318146883212116,0.459695421266741
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32624,-0.0331469501273736,0.0256161956970019,-0.0833546936934973,0.0170607934387502,0.195707478419956
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32624,-0.0258464694769096,0.0376570702887114,-0.099654327242784,0.0479613882889648,0.492502871008294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32624,0.0481506396093833,0.0325657001534501,-0.015678132691379,0.111979411910146,0.139294044507841
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32624,-0.0514538250022585,0.0479664263083207,-0.145468020566567,0.04256037056205,0.283435175120341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32624,0.0135809006242631,0.0255097330556196,-0.0364181761647512,0.0635799774132775,0.594476522835155
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32623,0.00792332440967828,0.0282356893859347,-0.0474186267867538,0.0632652756061103,0.779013726108238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32623,-0.0250177372711194,0.0394999006673995,-0.102437542579222,0.0524020680369836,0.52651498100578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32623,-0.00105524448233286,0.0838483540714073,-0.165398018462291,0.163287529497625,0.989959071922957
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32623,0.0718490777072793,0.0544346574933137,-0.0348428509796156,0.178541006394174,0.186900640411233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32623,-0.0500589400244442,0.0755296307591266,-0.198097016312332,0.0979791362634439,0.507495151304425
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32623,-0.0246394408725117,0.0401029432457748,-0.10324120963423,0.053962327889207,0.538964970659457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,32530,-0.022935237278589,0.0234214809155059,-0.0688413398729806,0.0229708653158026,0.327491026467186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,32603,0.0251926448737715,0.0209470894472971,-0.0158636504429309,0.0662489401904739,0.229135126899299
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29173.Frequency of feeling left out,32551,0.0255484996762467,0.0218303683887177,-0.01723902236564,0.0683360217181334,0.241906970402102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29174.Frequency of feeling isolated from others,32578,0.0278434664684647,0.0226586654964046,-0.0165675179044883,0.0722544508414178,0.21917414291476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,32641,-0.00519691621683707,0.0189711936652333,-0.0423804558006943,0.0319866233670202,0.78413977281196
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29176.Ability to make it through stressful events,32641,0.0012516108609448,0.0185465378031834,-0.0350996032332947,0.0376028249551843,0.946197347464785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29177.Quick recovery from stressful events,32641,-0.00546894484684891,0.0187908106909795,-0.0422989338011688,0.0313610441074709,0.771025361688211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29178.Hard to snap back when something bad happens,32641,0.0018910444672818,0.0186005746056431,-0.0345660817597787,0.0383481706943423,0.919024346504627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29179.Comes through difficult times with little trouble,32641,0.00862288642329126,0.0188773550475554,-0.0283767294699173,0.0456225023164998,0.647837944576903
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,32641,0.0178901805455462,0.0186631143018796,-0.0186895234861378,0.0544698845772301,0.337796185908298
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29181.General happiness,32594,0.028718107538779,0.0196006690117512,-0.0096992037242533,0.0671354188018114,0.142916022133598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29182.Belief that own life is meaningful,32504,-0.0201942797828686,0.0193365090415117,-0.0580938375042316,0.0177052779384944,0.296350149663651
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28906,0.0411330585968413,0.0257732993446594,-0.00938260811869107,0.0916487253123737,0.110569518043286
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2946.Father's age,29723,0.000943922051779607,0.0228204728956037,-0.0437842048236037,0.0456720489271629,0.967008116688356
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,29484,-0.00223356737669998,0.0175195177336914,-0.036571822134735,0.0321046873813351,0.898557498223906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47377,0.0884786769895989,0.00751685249196095,0.0737456461053554,0.103211707873842,6.82735802309374e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47377,-0.00325547925883138,0.00889821149408552,-0.020695973787239,0.0141850152695762,0.714474631871169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30020.Haemoglobin concentration,47377,-0.0748668103029617,0.00965582217486248,-0.0937922217656922,-0.0559413988402313,9.3072038219034e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30030.Haematocrit percentage,47377,-0.053531887452011,0.00937194402533279,-0.0719008977416632,-0.0351628771623587,1.13084451669562e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30040.Mean corpuscular volume,47377,-0.0523191753413407,0.00741241635537524,-0.0668475113978762,-0.0377908392848052,1.73336277725802e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47376,-0.0631768285268778,0.0074288523174319,-0.0777373790690443,-0.0486162779847113,1.93779500868503e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47376,-0.040369856777792,0.00729373454532017,-0.0546655764866195,-0.0260741370689644,3.14871839791067e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47377,0.0118809217665901,0.00702709608886367,-0.00189218656758267,0.0256540301007629,0.0909019866000682
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30080.Platelet count,47377,0.362544374354486,0.00704625871240199,0.348733707278178,0.376355041430794,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30090.Platelet crit,47377,0.294067950846764,0.0073802391490059,0.279602682114713,0.308533219578816,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47377,-0.218043876327174,0.00704915121454921,-0.231860212707691,-0.204227539946658,7.50589374864251e-206
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30110.Platelet distribution width,47377,-0.103376838998983,0.007172311270428,-0.117434569089022,-0.0893191089089439,6.84263022524887e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30120.Lymphocyte count,47346,0.0772229813427244,0.0074624913023609,0.0625964983900971,0.0918494642953518,4.84498468221165e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30130.Monocyte count,47346,0.0410829148905027,0.00760261869735604,0.0261817822436849,0.0559840475373206,6.59005402367676e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30140.Neutrophill count,47346,0.0678622369916703,0.00747525536051656,0.0532107364850579,0.0825137374982828,1.19020479585244e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30150.Eosinophill count,47346,0.0606078227298188,0.00737155241622687,0.0461595799940141,0.0750560654656234,2.10922845757778e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30160.Basophill count,47346,0.117013583347999,0.0123660243468989,0.0927761756280776,0.141250991067921,3.28720755451944e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,47346,0.0236841674946724,0.0543033052787034,-0.0827503108515862,0.130118645840931,0.66273494208782
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30180.Lymphocyte percentage,47346,0.00594188822141992,0.00739463835098092,-0.00855160294650268,0.0204353793893425,0.421670988615182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30190.Monocyte percentage,47346,-0.0236614912725978,0.00750177846172149,-0.0383649770575719,-0.0089580054876237,0.00161192313658675
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30200.Neutrophill percentage,47346,-0.00313064143053201,0.00733580262319818,-0.0175088145720004,0.0112475317109364,0.669556736356523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30210.Eosinophill percentage,47346,0.0327516980963688,0.00729170543375489,0.0184599554462093,0.0470434407465284,7.10229959643837e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30220.Basophill percentage,47346,-0.0213052870558332,0.00699288397202468,-0.0350113396410016,-0.00759923447066482,0.00231624444989919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47346,0.0238310540334832,0.0542896048213631,-0.0825765714163885,0.130238679483355,0.660693473606851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30240.Reticulocyte percentage,46942,0.0288684572847284,0.00769718720447863,0.0137819703639503,0.0439549442055065,0.000176910443704527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30250.Reticulocyte count,46942,0.0281603234036732,0.00795565698146372,0.0125672357200043,0.0437534110873421,0.000401450914388625
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,46942,-0.0416895935745849,0.00734246813860084,-0.0560808311262426,-0.0272983560229273,1.38061611966144e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30270.Mean sphered cell volume,46942,-0.0371853556854665,0.00742596801924107,-0.051740253003179,-0.022630458367754,5.55654500012196e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,46942,0.0023224465831669,0.00776744457425238,-0.0129017447823678,0.0175466379487016,0.764944708463766
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46942,0.021447503391917,0.00790769341987148,0.00594842428896894,0.0369465824948652,0.00668824976616142
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,46942,0.0200201385354161,0.00810913862387506,0.00412622683262101,0.0359140502382112,0.0135626849026118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30500.Microalbumin in urine,31052,0.0184314460763171,0.0143749329305036,-0.00974342246747007,0.0466063146201042,0.199819797594307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47421,-0.00260777815426473,0.00772114285711858,-0.0177412181542171,0.0125256618456877,0.735558372578047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30520.Potassium in urine,47377,0.00260552190445435,0.00718395904652503,-0.0114750378267347,0.0166860816356434,0.716842747063157
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30530.Sodium in urine,47352,0.00714691218931642,0.00755711904852415,-0.00766504114579091,0.0219588655244238,0.344301831633056
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30600.Albumin,44983,0.0510256246747633,0.00790210434766985,0.0355375001533304,0.0665137491961962,1.09031943425762e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30610.Alkaline phosphatase,47006,0.0356685175511347,0.00751473937140911,0.0209396283831728,0.0503974067190965,2.08262269359206e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30620.Alanine aminotransferase,47015,0.0197467237404031,0.00782710271793352,0.0044056024132534,0.0350878450675528,0.0116471220919342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30630.Apolipoprotein A,44783,-0.0148831275344778,0.0087243516066306,-0.0319828566834738,0.00221660161451819,0.0880365064759202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30640.Apolipoprotein B,46914,0.117861062418243,0.00742338120601111,0.103311235254462,0.132410889582025,1.85537393286741e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,46949,-0.00588181477386561,0.00755110682248434,-0.0206819841459349,0.00891835459820371,0.436026714636329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30660.Direct bilirubin,41972,-0.0529228335383072,0.0085024372894952,-0.0695876106257178,-0.0362580564508966,4.94295019486618e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30670.Urea,47004,-0.0114336101429905,0.00785954466600352,-0.0268383176883574,0.00397109740237636,0.1457546035444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30680.Calcium,44984,0.0835438724284984,0.00758569871910227,0.0686759029390579,0.0984118419179388,3.95093325728716e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30690.Cholesterol,47016,0.118250338411572,0.00765200304864669,0.103252412436224,0.133248264386919,1.34499920691258e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30700.Creatinine,47010,-0.0247483115999631,0.00870446973120181,-0.0418090722731187,-0.00768755092680761,0.00447069692958096
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30710.C-reactive protein,46959,0.0279156142590464,0.00818686521479739,0.0118693584380435,0.0439618700800493,0.000651233845508657
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30720.Cystatin C,47013,0.00961648092284071,0.00847701307377382,-0.00699846470175598,0.0262314265474374,0.256631072287809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,47012,0.0557819159784844,0.00770537828035739,0.040679374548984,0.0708844574079849,4.65292807116504e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30740.Glucose,44962,0.0361895645099833,0.00821596352516109,0.0200862760006676,0.052292853019299,1.06424225642854e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46927,0.0347987036722651,0.00836072690002147,0.018411678948223,0.0511857283963072,3.1642100656213e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30760.HDL cholesterol,44971,-0.0477293282761133,0.00914642118367339,-0.0656563137961131,-0.0298023427561134,1.8226926012696e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30770.IGF-1,46886,-0.00495571225569559,0.00752278799730225,-0.019700376730408,0.00978895221901681,0.510056620826039
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30780.LDL direct,46967,0.12121033347983,0.00744314307100596,0.106621773060658,0.135798893899001,2.76091109709864e-59
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30790.Lipoprotein A,42528,0.00266021309628379,0.00820734409508879,-0.0134261813300903,0.0187466075226578,0.745846441266086
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30810.Phosphate,44942,0.06612269648406,0.0081799920202023,0.0500899121244635,0.0821554808436565,6.64148303565215e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30830.SHBG,44755,-0.0543840299211395,0.00862558264923136,-0.071290171913633,-0.0374778879286461,2.94192892516377e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30840.Total bilirubin,46936,-0.0680526079941807,0.00754373999587701,-0.0828383383860996,-0.0532668776022618,2.00818970805785e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30850.Testosterone,43153,-2.76526678900033e-05,0.0134203209953937,-0.0263314818188617,0.0262761764830817,0.998355976267768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30860.Total protein,44979,0.117435429291756,0.00770311346030085,0.102337326909566,0.132533531673946,3.42387678304647e-52
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30870.Triglycerides,47010,0.188333189645982,0.00824678279078417,0.172169495376045,0.204496883915919,3.85981518363147e-114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30880.Urate,46983,0.0140392598577239,0.00921469466945726,-0.0040215416944123,0.0321000614098601,0.127629450823878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30890.Vitamin D,45698,-0.0503500976284419,0.0082109373836402,-0.0664435349003767,-0.0342566603565071,8.82699158489035e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3137.Number of measurements made,46055,-0.00135374208207675,0.0138040089311787,-0.028409599587187,0.0257021154230335,0.921878601222712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3143.Ankle spacing width,37827,-0.0178426186936543,0.0130458154674523,-0.0434124170098608,0.0077271796225522,0.171432415072283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37826,-0.00571185466625942,0.0105929036835295,-0.0264739458859772,0.0150502365534584,0.589747350189621
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3146.Speed of sound through heel,37827,-0.0211237916674641,0.0102265564120285,-0.0411678422350399,-0.00107974109988831,0.0388871753524195
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37827,-0.0166652443213262,0.0103538568922236,-0.0369588038300844,0.00362831518743206,0.10751563834473
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3148.Heel bone mineral density (BMD),37825,-0.016216072244645,0.0103287078083571,-0.0364603395490248,0.00402819505973493,0.116438747747525
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X3526.Mother's age at death,38577,-0.000109927007016872,0.00955178398884896,-0.0188314236251608,0.0186115696111271,0.990817885614913
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X3581.Age at menopause (last menstrual period),38030,-0.00162763060569565,0.00956172987672496,-0.0203686211640766,0.0171133599526853,0.864836949993772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29349,-0.0217242270219709,0.0164840379508348,-0.0540329414056071,0.0105844873616654,0.187600530732421
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4100.Ankle spacing width (left),32165,0.0134056724747768,0.0168302227965122,-0.0195815642063871,0.0463929091559408,0.425752182268395
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32164,-0.0156046933805148,0.0136317096069272,-0.042322844210092,0.0111134574490625,0.252354525921095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4103.Speed of sound through heel (left),32165,-0.0191037687235703,0.0133061987635669,-0.0451839183001613,0.00697638085302076,0.15112701168457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32165,-0.0184013329257679,0.0134117394353575,-0.0446883422190686,0.00788567636753276,0.170093442581494
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32163,-0.0176748962345331,0.0133759522164134,-0.0438917625787034,0.00854197010963716,0.186409399438342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32165,-0.0184129906117662,0.0134108555553661,-0.0446982675002838,0.00787228627675136,0.169794905023136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4119.Ankle spacing width (right),32164,0.0312418615650455,0.0166290635937654,-0.00135110307873471,0.0638348262088257,0.0603162562700602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32164,-0.000645807604201601,0.0136740038372833,-0.0274468551252769,0.0261552399168737,0.962332049648364
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4122.Speed of sound through heel (right),32164,-0.0114626170258456,0.0133765189494078,-0.0376805941666849,0.0147553601149938,0.391515295284905
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32164,-0.00836830375894351,0.0134651376440872,-0.0347599735413543,0.0180233660234673,0.534302706883558
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32161,-0.00948904102715566,0.0134406866469825,-0.0358327868552413,0.01685470480093,0.480213346404348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32164,-0.00837952518322064,0.0134651676420484,-0.0347712537616355,0.0180122033951942,0.533755629476214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4194.Pulse rate,32404,0.0313929080948426,0.0131865138524439,0.00554734094405265,0.0572384752456326,0.0173039932058365
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4195.Pulse wave reflection index,32404,-0.0200177513784917,0.0130542711355983,-0.0456041228042643,0.00556862004728084,0.125210847769358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4196.Pulse wave peak to peak time,32401,0.00516775591362639,0.0119200422749767,-0.0181955269453279,0.0285310387725806,0.664637885642177
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4198.Position of the pulse wave peak,32404,-0.00602898833556059,0.0115802187366614,-0.028726217059417,0.0166682403882958,0.60264030203788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4199.Position of pulse wave notch,32404,0.0290633433191256,0.0129136701343326,0.0037525498558338,0.0543741367824174,0.0244388919657385
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32404,0.000569864325480024,0.0115423259775779,-0.0220530945905727,0.0231928232415328,0.960624315890178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4269.Number of triplets attempted (left),32315,-0.0729985426828386,0.0605034964970641,-0.191585395817084,0.0455883104514071,0.227654280806785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4270.Volume level set by participant (left),32235,-0.0290148851301816,0.0193047279020176,-0.0668521518181361,0.00882238155777293,0.132881246924639
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4276.Number of triplets attempted (right),32318,-0.149323827792234,0.058534226800643,-0.264050912321495,-0.034596743262974,0.0107586411595969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4277.Volume level set by participant (right),32227,0.00229567623409718,0.0192095606865424,-0.035355062711526,0.0399464151797204,0.90487681369772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4288.Time to answer,32463,0.0515908517007836,0.0148391946561784,0.0225060301746739,0.0806756732268933,0.000510391974872474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4290.Duration screen displayed,32463,0.0322596202781623,0.0130330418840314,0.0067148581854607,0.057804382370864,0.0133360175362478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X46.Hand grip strength (left),48071,-0.00518173937992867,0.0108891123910359,-0.0265243996663591,0.0161609209065017,0.634175488931553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X47.Hand grip strength (right),48074,0.0104682976163857,0.010881840104782,-0.0108601089889871,0.0317967042217584,0.336060954204707
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X48.Waist circumference,48148,0.114780332704151,0.0144829221722527,0.086393805246536,0.143166860161766,2.37717945690763e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X4803.Tinnitus,32313,0.0169119052117724,0.0233331637694751,-0.0288210957763989,0.0626449061999436,0.46859557730416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4825.Noisy workplace,32441,0.0273117272095353,0.0333938979509548,-0.0381403127743362,0.0927637671934068,0.413458215768267
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4836.Loud music exposure frequency,32388,-0.0232267283409826,0.0383784972738362,-0.0984485829977017,0.0519951263157364,0.545062355516603
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X49.Hip circumference,48146,-0.0114246354408484,0.0123236323729275,-0.0355789548917864,0.0127296840100895,0.353909509720638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X50.Standing height,48143,-0.0097917947870219,0.0100777375927489,-0.0295441604688097,0.00996057089476593,0.331246418504549
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X5057.Number of older siblings,31515,-0.000757015814458618,0.0204569634742769,-0.0408526642240413,0.0393386325951241,0.970481835762095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X51.Seated height,48036,-0.0151898014117208,0.0101166542821583,-0.0350184438047511,0.00463884098130941,0.133248743804635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5181.Ever had eye surgery,29848,-0.0256469287721827,0.0475003032157907,-0.118747523075132,0.0674536655307671,0.589266289510683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29834,0.0217300524451303,0.0151181346831488,-0.00790149153384135,0.051361596424102,0.150676672807616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29835,0.0163290086108386,0.0150489942340885,-0.013167020087975,0.0458250373096521,0.277945234925846
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),29767,0.0112737872999371,0.0151800631953705,-0.0184791365629891,0.0410267111628634,0.457713928590275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),29767,0.026875743259938,0.0152671699868693,-0.00304790991432588,0.0567993964342019,0.0784039860614672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5199.logMAR, initial (right)",29816,0.00307044908679283,0.0243239246221129,-0.0446044431725484,0.050745341346134,0.899553292286182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5200.Final number of letters displayed (right),29816,-0.253941803154644,0.179569774124017,-0.605898560437718,0.0980149541284296,0.157370681575298
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5201.logMAR, final (right)",29773,0.00639108438887081,0.0157221744300101,-0.0244243774939491,0.0372065462716907,0.684390648174248
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5202.Number of rounds to result (right),29816,-0.0187430199495319,0.022854975709655,-0.0635387723404557,0.026052732441392,0.412204236738272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5206.logMAR, initial (left)",29816,-0.0134906252310995,0.0243190928672834,-0.0611560472509751,0.034174796788776,0.579099818472836
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5207.Final number of letters displayed (left),29816,-0.193682150919961,0.147216878377421,-0.482227232539707,0.0948629306997848,0.188356311674043
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5208.logMAR, final (left)",29762,-0.0166172496334666,0.0155342419997613,-0.0470643639529987,0.0138298646860655,0.28479513489419
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5209.Number of rounds to result (left),29814,0.0169824830355272,0.0228020637293928,-0.0277095618740827,0.061674527945137,0.45643844248271
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29566,0.0207316814497453,0.0155268699930843,-0.00970098373670001,0.0511643466361906,0.181866013822155
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29566,0.0265880661326017,0.0156154656847016,-0.00401824660941343,0.0571943788746168,0.0886896375469636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5256.Corneal hysteresis (right),29566,0.00469195758071301,0.015434389522016,-0.0255594458824383,0.0349433610438644,0.761145038758469
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5257.Corneal resistance factor (right),29566,0.0151341325758024,0.0154258233697098,-0.0151004812288288,0.0453687463804335,0.326594403078894
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29556,0.0142595798453441,0.0155260410135082,-0.0161714605411319,0.0446906202318201,0.358437256725196
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29556,0.00127866488174909,0.01536748078765,-0.0288415974620449,0.0313989272255431,0.933691094126697
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5264.Corneal hysteresis (left),29556,-0.0105053814387104,0.0156991023402241,-0.0412756220255497,0.0202648591481288,0.503416773993722
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5265.Corneal resistance factor (left),29556,-0.0059507399851699,0.0154975629989082,-0.0363259634630301,0.0244244834926903,0.701009947602119
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29178,0.117356175726059,0.104879288380169,-0.0882072294990722,0.322919580951189,0.263212266017234
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48071,0.00340829231741685,0.0418890410497455,-0.0786942281400843,0.085510812774918,0.935152552659688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48071,-0.0956396976168379,0.0435913858606888,-0.181078813903788,-0.0102005813298879,0.028244790871693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48071,-0.139619111538685,0.113819508723059,-0.36270534863588,0.0834671255585104,0.219958430446857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48071,-0.0811431108413037,0.0183831200890231,-0.117174026215789,-0.0451121954668185,1.01927064849784e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48071,0.0752280238490524,0.0168168977777185,0.042266904204724,0.108189143493381,7.73593225680529e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35355,0.00432238228887563,0.0209771593785385,-0.0367928500930598,0.045437614670811,0.836754264726281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35355,-0.00819553786811714,0.0516911957038875,-0.109510281447737,0.0931192057115023,0.874027903696436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35355,-0.0226010418064561,0.0409702130864803,-0.102902659455957,0.0577005758430452,0.581202426031447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35355,-0.00843155443784471,0.025194822120849,-0.0578134057947088,0.0409502969190194,0.737892349778929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48139,-0.0736345955414345,0.0343998778781742,-0.141058356182656,-0.00621083490021301,0.0323206723404816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48139,-0.0736345955414345,0.0343998778781742,-0.141058356182656,-0.00621083490021301,0.0323206723404816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48139,-0.0626884284634951,0.0277804101377278,-0.117138032333442,-0.00823882459354854,0.0240440584606887
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48139,-0.0902650718890167,0.0427496902850614,-0.174054464847737,-0.00647567893029637,0.0347416090454031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48139,-0.0913624412113198,0.108374895536391,-0.303777236462647,0.121052354040007,0.399224548931548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48139,-0.0136897297048933,0.0736401083914532,-0.158024342152142,0.130644882742355,0.852524416703558
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48139,0.158333319695625,0.116647269604918,-0.0702953287300157,0.386961968121265,0.174677110464704
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48071,0.00441749215091018,0.0223741307225878,-0.0394358040653618,0.0482707883671822,0.843486895272954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48071,0.00956454915347122,0.0373798819674466,-0.0637000195027241,0.0828291178096665,0.798050168942139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48071,0.00340420030112443,0.019870647569408,-0.0355422689349153,0.0423506695371642,0.863975167614223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48071,0.0485356197746737,0.0365161300406183,-0.0230359951049382,0.120107234654286,0.183809469260071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48071,-0.00157440444845715,0.0358191307499468,-0.0717799007183528,0.0686310918214385,0.964941211756591
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48071,0.0262202583495973,0.0199546663879355,-0.0128908877707563,0.0653314044699509,0.188861888105616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30746,-0.0637559799321609,0.0750786857912224,-0.210910204082957,0.083398244218635,0.395808535338407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30746,-0.0294978244704571,0.0492950244240085,-0.126116072341514,0.0671204234005996,0.54959890373457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30746,0.0528370568027752,0.0622032273409375,-0.0690812687854624,0.174755382391013,0.395676435100046
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30746,0.0808675763777983,0.0558495137062544,-0.0285974704864602,0.190332623242057,0.147679476582701
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48061,-0.0452490678524682,0.0545904137398735,-0.15224627878262,0.0617481430776837,0.407178975426876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48061,0.0686923355713889,0.0968673116396921,-0.121167595242408,0.258552266385185,0.478245564785981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48061,0.0285944911424789,0.157275289765832,-0.279665076798551,0.336854059083509,0.855732046481187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48061,-0.0809674623906296,0.148215317334918,-0.37146948436707,0.20953455958581,0.584876794652878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48061,-0.125482260899422,0.0454552474507011,-0.214574545902796,-0.036389975896048,0.0057745627346254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48061,0.162334324710527,0.0656946352240888,0.0335728396713129,0.291095809749741,0.0134789351431739
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48061,-0.00703377591017317,0.0322696883037444,-0.0702823649855121,0.0562148131651658,0.827455529922239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32575,0.0989936221358765,0.0496501629462036,0.00167930276131749,0.196307941510435,0.0462048118359961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32575,-0.0508320957451616,0.0565033365094074,-0.1615786353036,0.0599144438132769,0.36834386276973
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32575,0.0136480821931367,0.0739403903000502,-0.131275082794962,0.158571247181235,0.853561332008559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32575,0.012752851773692,0.0256622188300808,-0.0375450971332663,0.0630508006806503,0.619237426894556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35583,-0.0393271310194504,0.0257947077800556,-0.0898847582683592,0.0112304962294585,0.127382280691469
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35583,0.00353534755520633,0.0224988716375516,-0.0405624408543948,0.0476331359648075,0.875141746926268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35583,0.0442329177966318,0.0211446906888539,0.00278932404647812,0.0856765115467854,0.0364686270894796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35583,-0.00534460057186151,0.0505991024262461,-0.104518841327304,0.0938296401835808,0.915880688281649
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35583,0.0118200168597508,0.0301705429221636,-0.0473142472676898,0.0709542809871914,0.695233134160243
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35583,-0.00796324114054621,0.0352413498856689,-0.0770362869164573,0.0611098046353649,0.82123434663442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48071,-0.0428109955134475,0.0488307771549674,-0.138519318737184,0.0528973277102886,0.380646805754674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48071,0.0318100681477727,0.0312434116884268,-0.0294270187615439,0.0930471550570892,0.308623363209968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48071,-0.152091716982937,0.126851439022451,-0.400720537466942,0.0965371035010678,0.230549655892224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48071,-0.0444853269079511,0.0307434507843262,-0.10474249044523,0.0157718366293281,0.147914261354887
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48071,0.0232988586049155,0.0368241586292485,-0.0488764923084115,0.0954742095182426,0.526931909216552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48071,-0.0569171351754235,0.0412790549386166,-0.137824082855112,0.023989812504265,0.16795772322728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48071,-0.011662549272415,0.0147489257837787,-0.0405704438086213,0.0172453452637913,0.429104313772589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28200,-0.0534136648493975,0.048950845800831,-0.149357322619026,0.0425299929202312,0.275268473368589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28200,0.0379692634861337,0.0658248264444125,-0.0910473963449147,0.166985923317182,0.564093769206606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28200,0.0130389345405997,0.0432812735151619,-0.0717923615491176,0.097870230630317,0.763232629174055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28200,0.00453614491926464,0.0389082552073095,-0.071724035287062,0.0807963251255913,0.907194640276345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48176,0.0387352941939175,0.0168303255997571,0.00574785601839364,0.0717227323694414,0.0213710022515677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48176,0.0448288956594281,0.0452840759019821,-0.0439278931084569,0.133585684427313,0.322209467517752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48176,0.0513772904216363,0.0164526298327831,0.0191301359493814,0.0836244448938911,0.00179391206764105
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48176,-0.0371531539154723,0.01640013165636,-0.069297411961938,-0.0050088958690067,0.0234960143801558
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48176,0.0314573243416631,0.0236424277568662,-0.0148818340617946,0.0777964827451208,0.183351415282285
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48176,-0.00498750808200345,0.0209281282934497,-0.0460066395371649,0.036031623373158,0.811638061238052
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48176,-0.00209163902029049,0.0175776440470724,-0.0365438213525524,0.0323605433119714,0.905280898467236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48176,0.0973479890259185,0.047293478325769,0.00465277150741122,0.190043206544426,0.0395644867849573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40806,-0.0083388803797143,0.0176286151881378,-0.0428909661484644,0.0262132053890358,0.636197420032038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40806,-0.00396440221463187,0.0195076512488302,-0.0421993986623391,0.0342705942330754,0.838963312720624
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40806,0.0216825033242698,0.0195825904260036,-0.0166993739106973,0.0600643805592369,0.268209202035564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40806,0.0163313450731707,0.0249246247944679,-0.0325209195239865,0.0651836096703278,0.512329332678698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40806,-0.015031726313965,0.0177467369197228,-0.0498153306766217,0.0197518780486918,0.396999973696483
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47969,0.00514774464372835,0.0177259788920312,-0.0295951739846529,0.0398906632721096,0.771507609820726
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47969,0.0339028247327747,0.0143077720838864,0.00585959144835743,0.061946058017192,0.0178182997563793
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47969,-0.0048763787800113,0.015631552252482,-0.035514221194876,0.0257614636348534,0.755075645759922
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47969,0.0100681527795195,0.034455451946642,-0.0574645330358987,0.0776008385949378,0.77013030443596
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47980,0.0130548952940818,0.0161599235753242,-0.0186185549135537,0.0447283455017173,0.419181505477085
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47980,-0.0614303999412226,0.0292210225540854,-0.11870360414723,-0.00415719573521525,0.0355404672109235
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48071,0.01242743178082,0.0154110942145922,-0.0177783128797808,0.0426331764414208,0.420023156139815
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48071,0.0197268895801578,0.0174942000339793,-0.0145617424864416,0.0540155216467572,0.259489965556937
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48071,-0.0375711310800899,0.0227856258263015,-0.0822309576996409,0.007088695539461,0.0991822078615651
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48071,0.0607702993037015,0.0332050030292858,-0.00431150663369879,0.125852105241102,0.0672393737201879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48071,-0.00362930007721396,0.0340792521432806,-0.0704246342780439,0.063166034123616,0.91518982551654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48071,-0.0157599399795529,0.0442114244465337,-0.102414331894759,0.0708944519356532,0.721493602719881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37827,-0.0166768691511754,0.0103538441111725,-0.0369704036090736,0.00361666530672278,0.107270145823045
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,47634,-0.017231912897261,0.0111216887756006,-0.0390304228974381,0.0045665971029161,0.121299932684546
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X874.Duration of walks,44121,-0.00844681461997522,0.00798311774925274,-0.0240937254085106,0.00720009616856016,0.290029830618366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46704,0.00953983159144818,0.0107820603840212,-0.0115930067612333,0.0306726699441297,0.376280848309876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X894.Duration of moderate activity,41434,-0.000118048506150556,0.0131506611015517,-0.0258933442651919,0.0256572472528908,0.99283789399733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29464,0.0192147446605188,0.0167903535774342,-0.0136943483512523,0.0521238376722898,0.252515793981617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46729,0.00681968635854842,0.011094429535744,-0.0149253955315099,0.0285647682486068,0.53876268075559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X914.Duration of vigorous activity,36166,0.00383752137655405,0.0107741123155011,-0.0172797387618281,0.0249547815149362,0.721712318672425
